<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Sectioned Pathophysiology Quiz</title>
<style>
  :root { --bg:#0b1020; --card:#121a33; --ink:#eef3ff; --muted:#9db0ff; --accent:#6aa6ff; --good:#33d17a; --bad:#ef476f; }
  html,body{height:100%}
  body{margin:0;font-family:Inter,system-ui,Segoe UI,Roboto,Arial,sans-serif;background:linear-gradient(120deg,#0b1020,#111b36);color:var(--ink)}
  .wrap{max-width:1150px;margin:0 auto;padding:24px}
  header{display:flex;gap:16px;align-items:center;justify-content:space-between;margin-bottom:16px}
  h1{font-size: clamp(20px,3vw,28px);margin:0}
  .card{background:var(--card);border:1px solid #1f2a52;border-radius:16px;box-shadow:0 6px 24px rgba(0,0,0,.35)}
  .toolbar{display:flex;gap:8px;flex-wrap:wrap}
  button, select{background:#182347;color:var(--ink);border:1px solid #2a3a72;border-radius:12px;padding:10px 14px;cursor:pointer}
  button:hover{filter:brightness(1.12)}
  .pill{padding:8px 12px;border-radius:999px;background:#182347;border:1px solid #2a3a72;color:var(--muted);font-size:12px}
  .grid{display:grid;grid-template-columns:1fr;gap:16px}
  @media(min-width:1000px){.grid{grid-template-columns:1.1fr .9fr}}
  .qbox{padding:20px}
  .qmeta{display:flex;justify-content:space-between;align-items:center;margin-bottom:10px;color:var(--muted);font-size:13px}
  .qstem{font-size:18px;line-height:1.45}
  .choices{margin-top:14px;display:grid;gap:10px}
  .choice{background:#131b35;border:1px solid #263469;border-radius:12px;padding:12px;display:flex;gap:12px;align-items:flex-start}
  .choice input{margin-top:3px}
  .choice.correct{border-color:rgba(51,209,122,.9);background:rgba(51,209,122,.08)}
  .choice.incorrect{border-color:rgba(239,71,111,.9);background:rgba(239,71,111,.06)}
  .explain{margin-top:12px;padding:12px;border-left:3px solid #2a3a72;background:#0f1630;border-radius:8px}
  .panel{padding:16px}
  .stats{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:10px}
  .kpi{background:#0e1631;border:1px solid #243362;border-radius:12px;padding:12px}
  .kpi h3{margin:0 0 6px 0;font-size:12px;color:var(--muted)}
  .kpi .v{font-size:20px}
  .progress{height:10px;background:#101738;border-radius:999px;overflow:hidden}
  .bar{height:100%;background:linear-gradient(90deg,#6aa6ff,#9db0ff);width:0%}
  .footer{display:flex;gap:10px;justify-content:space-between;align-items:center;margin-top:8px}
  .tag{font-size:11px;color:#b9c9ff;background:#0f1630;border:1px solid #243362;border-radius:999px;padding:4px 8px}
  .muted{color:var(--muted)}
  .good{color:var(--good)}
  .bad{color:var(--bad)}
  details summary{cursor:pointer}
  .tabs{display:flex;gap:6px;flex-wrap:wrap;margin:8px 0 0}
  .tabs button{font-size:12px}
  .tabs button.active{outline:2px solid var(--accent)}
</style>
</head>
<body>
  <nav style="
  display:flex;
  gap:20px;
  justify-content:center;
  align-items:center;
  background:#121a33;
  border-bottom:1px solid #1f2a52;
  padding:12px;
  margin-bottom:20px;
  border-radius:0 0 12px 12px;
  box-shadow:0 4px 12px rgba(0,0,0,0.3)
">
  <a href="index.html" style="color:#eef3ff; text-decoration:none; font-weight:600;">
    ğŸ  Original Quiz
  </a>
  <a href="sectioned-quiz.html" style="color:#eef3ff; text-decoration:none; font-weight:600;">
    ğŸ“š Sectioned Quiz
  </a>
</nav>
<div class="wrap">
  <header>
    <h1>Pathophysiology Quiz â€” Sectioned Version</h1>
<div class="toolbar">
  <button id="startBtn">Start / Reset</button>
  <button id="shuffleBtn" title="Reshuffle the current pool and restart timer">Shuffle ğŸ”€</button>
  <button id="prevBtn">â—€ Back</button>
  <button id="submitBtn">Submit Answer</button>
  <button id="nextBtn">Next â–¶</button>
  <select id="mode">
    <option value="exam">Exam Mode</option>
    <option value="study">Study Mode (reveal after submit)</option>
    <option value="review">Review Incorrect Only</option>
  </select>
</div>

  </header>

  <div class="card" style="padding:14px">
    <strong>Sections:</strong>
    <div class="tabs" id="sectionTabs"></div>
    <div class="muted" style="margin-top:6px">Tip: Click a section to quiz that topic only. Click multiple to combine. â€œStart / Resetâ€ reshuffles the selected pool.</div>
  </div>

  <div class="grid" style="margin-top:14px">
    <section class="card qbox">
      <div class="qmeta">
        <div><span id="qIndex">1</span>/<span id="qTotal">0</span> â€¢ <span id="qCat" class="pill">Category</span></div>
        <div class="muted">Timer: <span id="timer">00:00</span></div>
      </div>
      <div id="qStem" class="qstem">Choose sections above, then press Start.</div>
      <div id="choices" class="choices"></div>
      <div id="explain" class="explain" style="display:none"></div>
      <div class="footer">
        <div id="tags"></div>
        <div class="progress" style="width:40%"><div class="bar" id="bar"></div></div>
      </div>
    </section>

    <aside class="card panel">
      <div class="stats">
        <div class="kpi"><h3>Score</h3><div class="v" id="score">0 / 0 (0%)</div></div>
        <div class="kpi"><h3>Answered</h3><div class="v" id="answered">0</div></div>
      </div>
      <details style="margin-top:10px" open>
        <summary><strong>Review Sheet</strong> (after submit)</summary>
        <div id="review" class="muted" style="margin-top:8px;font-size:13px"></div>
      </details>
      <details style="margin-top:10px" open>
  <summary><strong>Acronym Index</strong></summary>
  <ul style="font-size:13px; color:#b9c9ff; margin-top:6px; line-height:1.5">
    <li><strong>A2/A3 (albuminuria)</strong> â€“ A2: 30â€“300 mg/g; A3: >300 mg/g (albumin-to-creatinine ratio)</li>
    <li><strong>ACC/AHA</strong> â€“ American College of Cardiology / American Heart Association</li>
    <li><strong>ACEi</strong> â€“ Angiotensin-Converting Enzyme inhibitor</li>
    <li><strong>ACD</strong> â€“ Anemia of Chronic Disease</li>
    <li><strong>ACR</strong> â€“ Albumin-to-Creatinine Ratio</li>
    <li><strong>ACS</strong> â€“ Acute Chest Syndrome (sickle cell context)</li>
    <li><strong>ADCC</strong> â€“ Antibody-Dependent Cellular Cytotoxicity</li>
    <li><strong>AeIOU (dialysis)</strong> â€“ Acidosis, Electrolytes, Intoxications, Overload, Uremia</li>
    <li><strong>AAT</strong> â€“ Alpha-1 Antitrypsin</li>
    <li><strong>AIHA</strong> â€“ Autoimmune Hemolytic Anemia</li>
    <li><strong>AKI</strong> â€“ Acute Kidney Injury</li>
    <li><strong>ANA</strong> â€“ Antinuclear Antibody</li>
    <li><strong>ARB</strong> â€“ Angiotensin II Receptor Blocker</li>
    <li><strong>ARNI</strong> â€“ Angiotensin Receptorâ€“Neprilysin Inhibitor</li>
    <li><strong>ASCVD</strong> â€“ Atherosclerotic Cardiovascular Disease</li>
    <li><strong>ATN</strong> â€“ Acute Tubular Necrosis</li>
    <li><strong>BAFF (BLyS)</strong> â€“ B-cell Activating Factor (B Lymphocyte Stimulator)</li>
    <li><strong>BPH</strong> â€“ Benign Prostatic Hyperplasia</li>
    <li><strong>CAD</strong> â€“ Coronary Artery Disease</li>
    <li><strong>CCR5 / CXCR4</strong> â€“ Chemokine co-receptors used by HIV</li>
    <li><strong>CKD</strong> â€“ Chronic Kidney Disease</li>
    <li><strong>COPD</strong> â€“ Chronic Obstructive Pulmonary Disease</li>
    <li><strong>CTLA-4â€“Ig</strong> â€“ Cytotoxic T-Lymphocyte Antigen-4â€“Immunoglobulin (costimulation blocker)</li>
    <li><strong>CVA (tenderness)</strong> â€“ Costovertebral Angle (tenderness)</li>
    <li><strong>DHFR</strong> â€“ Dihydrofolate Reductase</li>
    <li><strong>DLCO</strong> â€“ Diffusing Capacity for Carbon Monoxide</li>
    <li><strong>DMARD</strong> â€“ Disease-Modifying Antirheumatic Drug</li>
    <li><strong>dsDNA (anti-)</strong> â€“ Antiâ€“double-stranded DNA antibody</li>
    <li><strong>EPO</strong> â€“ Erythropoietin</li>
    <li><strong>FeNa</strong> â€“ Fractional Excretion of Sodium</li>
    <li><strong>G3a/G3b/G4 (CKD)</strong> â€“ eGFR 45â€“59 / 30â€“44 / 15â€“29 mL/min/1.73mÂ²</li>
    <li><strong>G6PD</strong> â€“ Glucose-6-Phosphate Dehydrogenase</li>
    <li><strong>GN</strong> â€“ Glomerulonephritis</li>
    <li><strong>HbF</strong> â€“ Fetal Hemoglobin</li>
    <li><strong>HbS</strong> â€“ Sickle Hemoglobin</li>
    <li><strong>HDL</strong> â€“ High-Density Lipoprotein</li>
    <li><strong>HFmrEF</strong> â€“ Heart Failure with mildly reduced Ejection Fraction (41â€“49%)</li>
    <li><strong>HFpEF</strong> â€“ Heart Failure with preserved Ejection Fraction (â‰¥50%)</li>
    <li><strong>HFrEF</strong> â€“ Heart Failure with reduced Ejection Fraction (â‰¤40%)</li>
    <li><strong>HIV</strong> â€“ Human Immunodeficiency Virus</li>
    <li><strong>ICS</strong> â€“ Inhaled Corticosteroid</li>
    <li><strong>IVDU</strong> â€“ Intravenous Drug Use</li>
    <li><strong>JVD</strong> â€“ Jugular Venous Distension</li>
    <li><strong>LAMA</strong> â€“ Long-Acting Muscarinic Antagonist</li>
    <li><strong>LABA</strong> â€“ Long-Acting Beta-Agonist</li>
    <li><strong>LDH</strong> â€“ Lactate Dehydrogenase</li>
    <li><strong>LDL</strong> â€“ Low-Density Lipoprotein</li>
    <li><strong>LSB / RUSB</strong> â€“ Left Sternal Border / Right Upper Sternal Border</li>
    <li><strong>LTOT</strong> â€“ Long-Term Oxygen Therapy</li>
    <li><strong>LUTS</strong> â€“ Lower Urinary Tract Symptoms</li>
    <li><strong>MMA</strong> â€“ Methylmalonic Acid</li>
    <li><strong>MRA</strong> â€“ Mineralocorticoid Receptor Antagonist</li>
    <li><strong>MR</strong> â€“ Mitral Regurgitation</li>
    <li><strong>MS</strong> â€“ Mitral Stenosis</li>
    <li><strong>MMF</strong> â€“ Mycophenolate Mofetil</li>
    <li><strong>MTX</strong> â€“ Methotrexate</li>
    <li><strong>NYHA</strong> â€“ New York Heart Association (functional class)</li>
    <li><strong>PCP</strong> â€“ Pneumocystis pneumonia</li>
    <li><strong>PFT</strong> â€“ Pulmonary Function Test</li>
    <li><strong>PNH</strong> â€“ Paroxysmal Nocturnal Hemoglobinuria</li>
    <li><strong>PPI</strong> â€“ Proton Pump Inhibitor</li>
    <li><strong>RDW</strong> â€“ Red cell Distribution Width</li>
    <li><strong>RRT</strong> â€“ Renal Replacement Therapy (dialysis)</li>
    <li><strong>SABA</strong> â€“ Short-Acting Beta-Agonist</li>
    <li><strong>SGLT2</strong> â€“ Sodium-Glucose Cotransporter-2 (inhibitor)</li>
    <li><strong>SLE</strong> â€“ Systemic Lupus Erythematosus</li>
    <li><strong>TB</strong> â€“ Tuberculosis</li>
    <li><strong>TG</strong> â€“ Triglycerides</li>
    <li><strong>TIBC</strong> â€“ Total Iron-Binding Capacity</li>
    <li><strong>TSAT</strong> â€“ Transferrin Saturation</li>
    <li><strong>UA</strong> â€“ Urinalysis</li>
    <li><strong>UTI</strong> â€“ Urinary Tract Infection</li>
    <li><strong>VLDL</strong> â€“ Very-Low-Density Lipoprotein</li>
    <li><strong>WBC</strong> â€“ White Blood Cell</li>
  </ul>
</details>

    </aside>
  </div>

  <p class="muted" style="margin-top:14px">Built from your study guide (McCance & Huether 9e scope). Educational use only.</p>
</div>

<script>
// ==== Question Bank grouped by Section ====
// (Using the same validated items from your previous quiz, organized by section.)
const BANK = {
  'Immunity & Inflammation': [
    {cat:'Immunity', stem:'Type I hypersensitivity is driven primarily by which immunoglobulin and effector cell?', choices:['IgG and neutrophils','IgE and mast cells','IgM and macrophages','IgA and eosinophils'], answer:1, why:'Allergen cross-links IgE on mast cells/basophils â†’ rapid degranulation and late eosinophilic phase.'},
    {cat:'Immunity', stem:'In Type II hypersensitivity, tissue injury most commonly results from:', choices:['Immune complex deposition','T cell cytotoxicity','Antibody binding to cell-surface antigens activating complement/ADCC','Eosinophil degranulation'], answer:2, why:'IgG/IgM against cell/ECM antigens â†’ complement, opsonization, NK-mediated ADCC, receptor dysfunction.'},
    {cat:'Immunity', stem:'Serum sickness and post-streptococcal GN are classic examples of:', choices:['Type I','Type II','Type III','Type IV'], answer:2, why:'Type III = immune complexâ€“mediated with complement activation and neutrophilic inflammation.'},
    {cat:'Immunity', stem:'Contact dermatitis from nickel exposure exemplifies:', choices:['Immediate histamine release','Immune complex deposition','Antibody blockade of receptors','Delayed T-cellâ€“mediated inflammation'], answer:3, why:'Type IV (delayed) hypersensitivity: sensitized T cells drive dermatitis 24â€“72 h post-exposure.'},
    {cat:'Immunity', stem:'First-line medication for anaphylaxis is:', choices:['Diphenhydramine IM','Epinephrine IM','Albuterol neb','Methylprednisolone IV'], answer:1, why:'Epinephrine IM (anterolateral thigh) is lifesaving; others are adjuncts.'},
    {cat:'Immunity', stem:'Graves disease and myasthenia gravis illustrate which Type II submechanism?', choices:['Complement cytolysis','Opsonization','Receptor dysfunction (stimulatory/blocking)','ADCC'], answer:2, why:'TSH receptor stimulation in Graves; AChR blockade in MG.'},
    {cat:'Immunity', stem:'Which autoantibody is most specific for SLE?', choices:['ANA','Anti-dsDNA','Anti-RNP','Anti-Sm'], answer:3, why:'Anti-Sm is highly specific (anti-dsDNA also specific and tracks nephritis).'},
    {cat:'Immunity', stem:'Low C3/C4 during an SLE flare indicates:', choices:['Drug toxicity','Active immune complex consumption','Lab artifact','Remission'], answer:1, why:'Complement consumption indicates active Type III immune complex disease.'},
    {cat:'Immunity', stem:'Foundation disease-modifying therapy for most SLE patients is:', choices:['Cyclophosphamide','Hydroxychloroquine','Azathioprine','Belimumab'], answer:1, why:'Hydroxychloroquine improves survival and reduces flares.'},
    {cat:'Immunity', stem:'Alloimmunity refers to responses against:', choices:['Self-antigens','Environmental allergens','Antigens from same species but genetically different','Microbial superantigens'], answer:2, why:'E.g., transfusion reactions, HDFN, transplant rejection.'},
    {cat:'Immunity', stem:'Primary immunodeficiencies are typically due to:', choices:['Acquired infections','Genetic/intrinsic defects','Medication effects','Nutrition alone'], answer:1, why:'Primary = inborn errors; secondary = acquired (HIV, chemo).'},
    {cat:'Immunity', stem:'Common variable immunodeficiency is characterized by:', choices:['High IgG with low IgA','Low IgG with poor vaccine response and recurrent sinopulmonary infections','Isolated IgM deficiency','Neutropenia with giant granules'], answer:1, why:'CVID: low IgG and low IgA/Â±IgM, poor vaccine response; treat with IVIG/SCIG.'},
    {cat:'Immunity', stem:'HIV primarily targets which cells via CD4 with CCR5/CXCR4?', choices:['CD8 T cells','B cells','CD4 T cells and macrophages/dendritic cells','NK cells'], answer:2, why:'gp120 binds CD4 and chemokine co-receptors.'},
    {cat:'Immunity', stem:'Triad suggesting active SLE nephritis:', choices:['Proteinuria, RBC casts, rising creatinine','Eosinophiluria, stones, edema','Bland UA, low complement, hypernatremia','Glycosuria, ketonuria, hyperkalemia'], answer:0, why:'Active GN shows proteinuria, RBC casts, and renal function decline.'},
    {cat:'Immunity', stem:'Belimumab mechanism in SLE:', choices:['TNF-Î± inhibition','BAFF (BLyS) inhibition reducing B-cell survival','IL-6 receptor blockade','CTLA-4â€“Ig costimulation blockade'], answer:1, why:'Targets soluble BLyS/BAFF.'},
    {cat:'Immunity', stem:'First-line topical therapy for localized allergic contact dermatitis:', choices:['Topical calcineurin inhibitor for all areas','High-potency topical corticosteroid on thick skin','Systemic steroids always','Topical antibiotic'], answer:1, why:'Use mediumâ€“high potency steroids for localized thick skin; lower for face/flexures.'},
    {cat:'Immunity', stem:'Type III hypersensitivity causes vasculitis primarily through:', choices:['Th2 cytokines','Immune complex complement activation recruiting neutrophils','Mast cell degranulation only','Eosinophil extracellular traps'], answer:1, why:'Complement activation (C5a/C3a) drives neutrophilic injury.'},
    {cat:'Immunity', stem:'Role of glucocorticoids in SLE flares is to:', choices:['Cure disease','Rapidly suppress inflammation while steroid-sparing agent is optimized','Replace hydroxychloroquine','Prevent infection'], answer:1, why:'Use the lowest effective dose and add DMARD/biologic for sparing.'},
    {cat:'Immunity', stem:'Example of secondary immunodeficiency:', choices:['X-linked agammaglobulinemia','DiGeorge syndrome','HIV infection','Wiskottâ€“Aldrich'], answer:2, why:'HIV is acquired.'},
    {cat:'Immunity', stem:'Which SLE antibody correlates best with nephritis activity over time?', choices:['Anti-Sm','Anti-Ro','Anti-dsDNA','Anti-centromere'], answer:2, why:'Anti-dsDNA tracks renal activity.'},
    {cat:'Immunity', stem:'Which clinical features are most characteristic of SLE?', choices:['Photosensitive malar rash, oral ulcers, serositis','Psoriatic plaques, nail pitting, uveitis','Proximal muscle weakness, heliotrope rash','Chorea, erythema marginatum'], answer:0, why:'Common SLE findings: malar/discoid rash, photosensitivity, oral/nasal ulcers, arthritis, serositis, nephritis, cytopenias.'},
    {cat:'Immunity', stem:'Best initial test when SLE is suspected:', choices:['Anti-Sm','ANA by immunofluorescence','Complement levels','Anti-CCP'], answer:1, why:'ANA is sensitive for screening; anti-dsDNA/anti-Sm add specificity.'},
    {cat:'Immunity', stem:'Type I hypersensitivity long-term controller to reduce reactions to allergens (e.g., allergic rhinitis):', choices:['Allergen immunotherapy','Epinephrine autoinjector daily','Systemic steroids long term','Macrolide prophylaxis'], answer:0, why:'Allergen immunotherapy induces tolerance and reduces IgE-mediated responses.'},
    {cat:'Immunity', stem:'HIV pathophysiology includes which early event after mucosal exposure?', choices:['Neutrophilic abscess formation','Infection of dendritic cells and CD4 T cells in mucosa with high viremia','Immediate antibody-mediated clearance','Latent infection limited to B cells'], answer:1, why:'Local infection and rapid systemic viremia precede seroconversion; progressive CD4 loss follows.'},
    {cat:'Immunity', stem:'Management of severe SLE nephritis typically includes:', choices:['NSAIDs alone','High-dose glucocorticoids plus mycophenolate or cyclophosphamide','Hydroxychloroquine monotherapy','TNF-Î± inhibitor'], answer:1, why:'Induction with steroids + MMF or cyclophosphamide; maintenance with MMF/azathioprine; HCQ for all unless contraindicated.'},
    {cat:'Immunity', stem:'Which challenge makes diagnosing SLE based solely on pulmonary manifestations difficult?', choices:['Pulmonary signs are specific to SLE','Pulmonary features overlap with infections, drug reactions, and other autoimmune diseases','Pulmonary involvement is never seen in SLE','SLE only affects skin and joints'], answer:1, why:'SLE lung disease mimics other causes (infection, drugs, vasculitis), so systemic criteria are needed.'},
    {cat:'Immunity', stem:'Example of a primary immunodeficiency:', choices:['HIV infection','X-linked agammaglobulinemia','Steroid therapy','Chemotherapy-related neutropenia'], answer:1, why:'Primary = congenital/inherited defects. Secondary = acquired.'},
    {cat:'Immunity', stem:'At what CD4 count do opportunistic infections like Pneumocystis pneumonia usually appear in HIV?', choices:['>800','200â€“500','<200','<50'], answer:2, why:'PCP risk rises at <200 CD4 cells/ÂµL.'},
    {cat:'Immunity', stem:'Type II hypersensitivityâ€”general treatment principle:', choices:['Epinephrine only','Remove/avoid offending antigen, immunosuppression (e.g., steroids), and in severe cases plasmapheresis/IVIG','Antibiotics only','Allergen immunotherapy'], answer:1, why:'Antibody-mediated diseases often respond to immunosuppression and, when needed, antibody removal.'},
    {cat:'Immunity', stem:'Type III immune-complex diseaseâ€”treatment often includes:', choices:['High-dose antihistamines alone','NSAIDs Â± glucocorticoids and treat inciting antigen (e.g., stop drug, treat infection)','Anticoagulation only','Desensitization shots'], answer:1, why:'Reduce inflammation and remove the trigger.'},
    {cat:'Immunity', stem:'Hypersensitivity is best defined as:', choices:[
    'Disturbance in immunologic tolerance of self-antigens',
    'Immunologic reaction of one person to the tissue of another person',
    'Altered immunologic response to an antigen that results in disease',
    'Undetectable immune response in the presence of antigens'
  ], answer:2, why:'By definition, hypersensitivity is an altered immune response to an antigen that harms the host.'},

  {cat:'Immunity', stem:'A hypersensitivity reaction that produces an allergic response is called:', choices:[
    'Hemolytic shock','Anaphylaxis','Necrotizing vasculitis','Systemic erythematosus'
  ], answer:1, why:'Systemic, severe type I reactions manifest as anaphylaxis (e.g., stings, peanuts, fish).'},

  {cat:'Immunity', stem:'The common hay-fever allergy is mediated primarily by:', choices:[
    'IgE','IgG','IgM','T cells'
  ], answer:0, why:'Type I allergy is IgE-mediated with mast cell involvement.'},

  {cat:'Immunity', stem:'Which antibody class mediates type I hypersensitivity?', choices:[
    'IgA','IgE','IgG','IgM'
  ], answer:1, why:'Type I reactions are mediated by antigen-specific IgE.'},

  {cat:'Immunity', stem:'Blood transfusion reactions are an example of:', choices:[
    'Autoimmunity','Alloimmunity','Homoimmunity','Hypersensitivity'
  ], answer:1, why:'Alloimmunity = immune response to antigens of another individual of the same species (e.g., ABO).'},

  {cat:'Immunity', stem:'During an IgE-mediated hypersensitivity reaction, which leukocyte is characteristically activated?', choices:[
    'Neutrophils','Monocytes','Eosinophils','T lymphocytes'
  ], answer:2, why:'Eosinophils are recruited and activated in IgE-mediated allergy.'},

  {cat:'Immunity', stem:'In IgE-mediated reactions, what primarily causes bronchospasm?', choices:[
    'Bronchial edema from anaphylatoxins',
    'Edema from cytotropic antibody binding',
    'Histamine acting at H1 receptors causing smooth muscle contraction',
    'Histamine acting at H2 receptors causing smooth muscle contraction'
  ], answer:2, why:'Histamine via H1 â†’ bronchial smooth muscle contraction and bronchospasm.'},

  {cat:'Immunity', stem:'Atopic individuals are genetically predisposed to allergy because they tend to have:', choices:[
    'Greater quantities of histamine',
    'More histamine receptors',
    'Greater quantities of IgE (and more FcÎµ receptors on mast cells)',
    'A deficiency in epinephrine'
  ], answer:2, why:'Atopy is associated with higher IgE and increased FcÎµRI on mast cells.'},

  {cat:'Immunity', stem:'Primary mechanism in type II hypersensitivity:', choices:[
    'Antibodies coat mast cells to trigger degranulation',
    'Antibodies bind soluble antigens forming circulating complexes',
    'Cytotoxic T cells directly lyse targets',
    'Antibodies bind antigens on cell surfaces (tissue-specific)'
  ], answer:3, why:'Type II = antibody binding to cell/ECM antigens â†’ complement/ADCC/receptor effects.'},

  {cat:'Immunity', stem:'ABO-mismatched transfusion causes erythrocyte destruction primarily by:', choices:[
    'Complement-mediated lysis','Phagocytosis by macrophages','Phagocytosis in spleen','Natural killer cells'
  ], answer:0, why:'IgM anti-A/anti-B efficiently fix complement â†’ intravascular hemolysis.'},

  {cat:'Immunity', stem:'When antibodies form against Rh antigens on RBCs, the cells are most often destroyed by:', choices:[
    'Complement-mediated lysis','Phagocytosis by macrophages (blood)',
    'Phagocytosis in the spleen','Neutrophil granules'
  ], answer:2, why:'Low-density coating â†’ Fc-mediated clearance in the spleen (extravascular hemolysis).'},

  {cat:'Immunity', stem:'In type III hypersensitivity, tissue damage from immune complexes is largely due to:', choices:[
    'Cytotoxic T cells','NK cells','Complement activation with neutrophil recruitment','Mast-cell degranulation'
  ], answer:2, why:'Complement (C3a/C5a) recruits/activates neutrophils; their enzymes/ROS injure tissue.'},

  {cat:'Immunity', stem:'Which submechanism of type II hypersensitivity best explains Graves disease?', choices:[
    'Complement-mediated cytolysis','Antibody-dependent cellular cytotoxicity',
    'Receptor modulation (stimulatory/blocking)','Neutrophil-mediated damage'
  ], answer:2, why:'TSH-receptorâ€“stimulating antibodies cause hyperthyroidism (receptor modulation).'},

  {cat:'Immunity', stem:'Type III hypersensitivity results from:', choices:[
    'Mast cell coating by antibody and degranulation',
    'Antibodies binding soluble antigens with deposition of immune complexes in tissues',
    'Tc/Th1 cells directly destroying targets',
    'Antibodies binding cell-surface antigens'
  ], answer:1, why:'Circulating immune complexes deposit in vessel walls/extravascular tissues.'},

  {cat:'Immunity', stem:'Type IV hypersensitivity is mediated by:', choices:[
    'Mast cells','Immune complexes','T lymphocytes (Th1/Tc)','Antibodies'
  ], answer:2, why:'Type IV is cell-mediated (delayed) via Th1 cytokines and/or cytotoxic T cells.'},

  {cat:'Immunity', stem:'Raynaud phenomenon (immune-complex form) is best explained by:', choices:[
    'Cytotoxic T-cell destruction of capillaries',
    'Immune complex deposition in cold-exposed capillary beds',
    'IgE-mediated mast-cell degranulation',
    'Autoantibody blockade of Î²2 receptors'
  ], answer:1, why:'Temperature-dependent immune complex deposition impairs perfusion.'},

  {cat:'Immunity', stem:'Maternal sensitization to fetal antigens is an example of:', choices:[
    'T-cell immunity','Alloimmunity','Autoimmunity','Fetal immunity'
  ], answer:1, why:'Response to antigens from a genetically different individual of the same species.'},

  {cat:'Immunity', stem:'SLE tissue damage is primarily caused by:', choices:[
    'Hemolysis by warm autoantibodies',
    'Pernicious anemia',
    'Deposition of immune complexes containing anti-DNA',
    'Receptor blockade at neuromuscular junction'
  ], answer:2, why:'Type III immune complex deposition drives many SLE manifestations.'},

  {cat:'Immunity', stem:'Why does acute rejection occur after organ transplantation?', choices:[
    'Primarily Th1/Tc cellâ€“mediated response against unmatched donor HLA antigens',
    'Circulating immune complexes lyse endothelium via complement',
    'NK-cell recognition of â€œmissing selfâ€ only',
    'Mast-cellâ€“mediated degranulation on graft endothelium'
  ], answer:0, why:'Recipient Th1 cytokines activate macrophages; Tc cells attack graft endothelium.'},

  {cat:'Immunity', stem:'Which blood cell carries the carbohydrate antigens for ABO blood type?', choices:[
    'Platelets','Neutrophils','Lymphocytes','Erythrocytes'
  ], answer:3, why:'ABO antigens are on RBC surfaces.'},

  {cat:'Immunity', stem:'A person with type O blood typically has naturally occurring antibodies against:', choices:[
    'A','B','A and B','O'
  ], answer:2, why:'Type O has both anti-A and anti-B isohemagglutinins.'},

  {cat:'Immunity', stem:'Isohemagglutinins (naturally occurring ABO antibodies) are primarily which class?', choices:[
    'IgA','IgE','IgG','IgM'
  ], answer:3, why:'ABO isohemagglutinins are classically IgM.'},

  {cat:'Immunity', stem:'Recurrent infections with viruses, fungi, or yeasts most strongly suggest deficiency of:', choices:[
    'NK cells','B cells','Macrophages','T cells'
  ], answer:3, why:'Cell-mediated (T-cell) defects predispose to these pathogens.'},

  {cat:'Immunity', stem:'Primary immunodeficiency with partial/complete absence of T-cell immunity:', choices:[
    'Bruton (X-linked agammaglobulinemia)','DiGeorge syndrome','Reticular dysgenesis','Adenosine deaminase deficiency'
  ], answer:1, why:'DiGeorge: thymic hypoplasia â†’ T-cell deficiency.'},

  {cat:'Immunity', stem:'By what age are infants typically protected by antibodies produced by their own B cells?', choices:[
    '1â€“2 months','4â€“5 months','6â€“8 months','10â€“12 months'
  ], answer:2, why:'Endogenous humoral immunity is generally adequate by ~6â€“8 months.'},

  {cat:'Immunity', stem:'Severe deficits in calories/protein most prominently cause deficiencies in:', choices:[
    'B-cell numbers','T-cell function and numbers','NK-cell function','Neutrophil count'
  ], answer:1, why:'Protein-calorie malnutrition depresses T-cell immunity.'},

  {cat:'Immunity', stem:'Urticaria (hives) is a manifestation of which hypersensitivity type?', choices:[
    'Type IV','Type III','Type II','Type I'
  ], answer:3, why:'Classic IgE-mediated type I reaction.'},

  {cat:'Immunity', stem:'Graves disease results from:', choices:[
    'Increased total immunoglobulins',
    'T-cell infiltration of thyroid only',
    'Autoantibodies binding to TSH-receptor sites (stimulatory)',
    'Exposure to rubber acetylates'
  ], answer:2, why:'TSH-receptorâ€“stimulating antibodies drive hyperthyroidism.'},

  {cat:'Immunity', stem:'Which cellular mediators produce the induration of a positive tuberculin skin test (PPD)?', choices:[
    'Histamine and complement products',
    'Immune complexes',
    'T lymphocytes and macrophages',
    'Basophils and eosinophils'
  ], answer:2, why:'Type IV delayed reaction with Th1 cells and macrophage recruitment.'},

  {cat:'Immunity', stem:'Which exposure is a classic trigger of type IV (delayed) hypersensitivity?', choices:[
    'Penicillin anaphylaxis','Poison ivy resin (urushiol)','Allergic rhinitis to ragweed','Immediate latex anaphylaxis'
  ], answer:1, why:'Contact dermatitis to plant resins/metals/topical antibiotics is type IV.'},

  {cat:'Immunity', stem:'Which disorder is an autoimmune disease?', choices:[
    'Crohn disease','Nonâ€“insulin-dependent diabetes (type 2)','Osteoarthritis','Gout'
  ], answer:0, why:'Crohn disease is immune-mediated; type 2 DM is not primarily autoimmune.'},

  {cat:'Immunity', stem:'Natural killer (NK) cells destroy antibody-coated targets in which mechanism?', choices:[
    'Complement-mediated lysis','Phagocytosis','ADCC (antibody-dependent cellular cytotoxicity)','Neutralization'
  ], answer:2, why:'Fc receptor on NK binds IgG on target â†’ cytotoxic granule release (a type II submechanism).'},
     {cat:'Immunity', stem:'Best **initial** therapy for severe Type I hypersensitivity (anaphylaxis):', choices:[
    'IM epinephrine','IV antihistamines','Nebulized albuterol only','Oral steroids'
  ], answer:0, why:'IM epinephrine is first-line and lifesaving; others are adjuncts.'},

  {cat:'Immunity', stem:'General treatment principle for **Type II** antibody-mediated disease:', choices:[
    'Allergen immunotherapy',
    'Remove offending antigen and use immunosuppression; consider plasmapheresis/IVIG when severe',
    'Desensitization with oral antigen',
    'Antibiotics only'
  ], answer:1, why:'Reduce antibody production/effects and remove the trigger when possible.'},

  {cat:'Immunity', stem:'Typical management approach for **Type III** immune-complex vasculitis:', choices:[
    'High-dose antihistamines only',
    'Treat inciting cause (drug/infection) and use anti-inflammatories Â± steroids',
    'Epinephrine autoinjector as sole therapy',
    'No therapy needed'
  ], answer:1, why:'Remove trigger and suppress inflammation; consider immunosuppression for severe disease.'},

  {cat:'Immunity', stem:'Treatment focus for **Type IV** contact dermatitis:', choices:[
    'Antibiotics',
    'Topical corticosteroids (systemic if severe) and trigger avoidance',
    'Daily epinephrine',
    'Complement inhibitors'
  ], answer:1, why:'T-cell mediated dermatitis improves with steroids and avoidance.'},
     {cat:'Immunity', stem:'Which mediator drives the LATE phase of Type I hypersensitivity (hours after exposure)?', choices:['Histamine only','Leukotrienes and cytokines (IL-5, IL-13) with eosinophils','Complement MAC','Bradykinin alone'], answer:1, why:'Late phase is eosinophil-rich and leukotriene/cytokine mediated.'},
  {cat:'Immunity', stem:'Which finding best supports **Type II** hypersensitivity from a drug (e.g., penicillin)?', choices:['Prick test wheal in minutes','Granulomatous inflammation','Direct Coombs-positive hemolysis','Tuberculin-type induration at 48h'], answer:2, why:'Drug-dependent antibodies cause RBC coating â†’ positive DAT.'},
  {cat:'Immunity', stem:'Which clinical picture is most consistent with **Type III** hypersensitivity?', choices:['Immediate hives after shellfish','Vesicular dermatitis to nickel at 48h','Immune-complex small-vessel vasculitis after new antibiotic','Myasthenia gravis'], answer:2, why:'Circulating ICs deposit in vessel walls â†’ palpable purpura.'},
  {cat:'Immunity', stem:'In **Type IV** hypersensitivity, which cell is the main effector?', choices:['B cell','Th1/Tc cells','Mast cell','Basophil'], answer:1, why:'T-cellâ€“mediated delayed reaction.'},
  {cat:'Immunity', stem:'Which alloimmune condition results from maternal antibodies against fetal RBC antigens?', choices:['Hyperacute rejection','GVHD','Hemolytic disease of the newborn','Arthus reaction'], answer:2, why:'Maternal anti-Rh/other RBC antibodies cross placenta.'},
  {cat:'Immunity', stem:'Earliest immunologic event in mucosal **HIV** transmission:', choices:['Neutralizing antibodies block entry','Infection of dendritic cells/CD4 T cells with local amplification and viremia','Immediate latent infection only','Cytotoxic NK clearance prevents spread'], answer:1, why:'Local infection precedes systemic viremia.'},
  {cat:'Immunity', stem:'Lab pattern most compatible with **CVID**:', choices:['High IgG/IgA, normal vaccine response','Low IgG with impaired vaccine response and recurrent sinopulmonary infections','Isolated IgA deficiency only','Neutropenia with giant granules'], answer:1, why:'Hypogammaglobulinemia + poor response; treat with IVIG/SCIG.'},
  {cat:'Immunity', stem:'Primary vs secondary immunodeficiencyâ€”best pair:', choices:['CVIDâ€”secondary; HIVâ€”primary','CVIDâ€”primary; HIVâ€”secondary','DiGeorgeâ€”secondary; chemoâ€”primary','XLAâ€”secondary'], answer:1, why:'CVID/XLA are primary; HIV/chemo are secondary.'},
  {cat:'Immunity', stem:'Most **specific** autoantibody for SLE:', choices:['ANA','Anti-Sm','Anti-Ro','RF'], answer:1, why:'Anti-Sm is highly specific (anti-dsDNA also specific).'},
  {cat:'Immunity', stem:'Belimumab targets:', choices:['TNF-Î±','BAFF/BLyS','IL-6 receptor','CTLA-4'], answer:1, why:'Inhibits B-cell activating factor.'},
  {cat:'Immunity', stem:'First-line long-term therapy that reduces SLE flares and improves survival:', choices:['Hydroxychloroquine','High-dose steroids indefinitely','Cyclophosphamide for all','Rituximab for all'], answer:0, why:'HCQ for virtually all unless contraindicated.'},
  {cat:'Immunity', stem:'Contact dermatitis management (localized, not face/flexures):', choices:['Topical high-potency corticosteroid','Systemic antibiotics','Daily epinephrine','Antifungals'], answer:0, why:'Steroids + avoidance; low-potency on face/flexures.'},
  {cat:'Immunity', stem:'Mechanism linking **low complement (C3/C4)** to SLE flare:', choices:['Decreased production from liver','Immune-complex consumption','Drug effect','Lab artifact'], answer:1, why:'Complement consumed by immune-complex activation.'},
  {cat:'Immunity', stem:'Which is **not** typically Type II?', choices:['Autoimmune hemolytic anemia','Graves disease','Myasthenia gravis','Serum sickness'], answer:3, why:'Serum sickness = Type III (immune complexes).'},
  {cat:'Immunity', stem:'Which vaccine is generally **contraindicated** in severe immunodeficiency?', choices:['Inactivated influenza','Pneumococcal','Live attenuated varicella','Recombinant zoster (ShingrixÂ®)'], answer:2, why:'Avoid live attenuated vaccines in immunocompromised hosts.'},
],
 
  'Hematology': [
    {cat:'Hematology', stem:'Microcytic anemia is most commonly caused by:', choices:['Vitamin B12 deficiency','Iron deficiency','Alcohol use disorder','Hypothyroidism'], answer:1, why:'Iron deficiency is the most prevalent cause of microcytosis.'},
    {cat:'Hematology', stem:'Iron deficiency studies show:', choices:['Low ferritin, low iron, high TIBC, low TSAT','High ferritin, low iron, low TIBC','Normal ferritin, high iron, high TIBC','High ferritin, high iron, low TIBC'], answer:0, why:'Ferritin drops first; TIBC rises.'},
    {cat:'Hematology', stem:'Anemia of chronic disease typically demonstrates:', choices:['Low iron, high TIBC, low ferritin','Low iron, low TIBC, normal/high ferritin','High iron, high TIBC, high ferritin','Normal iron, normal TIBC, low ferritin'], answer:1, why:'Inflammation â†’ hepcidin â†‘ â†’ iron sequestration; ferritin often normal/high.'},
    {cat:'Hematology', stem:'Folate deficiency pattern:', choices:['â†‘MMA and â†‘homocysteine','Normal MMA with â†‘homocysteine','Normal both','â†‘MMA with normal homocysteine'], answer:1, why:'Folate deficiency â†’ â†‘homocysteine; MMA normal (vs B12).'},
    {cat:'Hematology', stem:'Sickle cell vaso-occlusion is driven by:', choices:['Thrombin excess','HbS polymerization during deoxygenation causing rigid RBCs','Autoantibody hemolysis','Platelet GP IIb/IIIa dysfunction'], answer:1, why:'Deoxygenated HbS polymerizes â†’ rigidity and occlusion.'},
    {cat:'Hematology', stem:'Hemolysis lab pattern:', choices:['Low LDH, high haptoglobin','High LDH, low haptoglobin, indirect hyperbilirubinemia','Low reticulocyte count','Low unconjugated bilirubin'], answer:1, why:'Cell lysis releases LDH; haptoglobin consumed; unconjugated bilirubin rises.'},
    {cat:'Hematology', stem:'Erythropoietin is produced by:', choices:['Kupffer cells','Renal peritubular interstitial cells','Bone marrow macrophages','Splenic red pulp'], answer:1, why:'Stimulated by renal hypoxia.'},
    {cat:'Hematology', stem:'Adult risk factor strongly associated with iron deficiency:', choices:['Sun exposure','Chronic GI blood loss','High vitamin C intake','High calcium intake'], answer:1, why:'GI blood loss is key, especially in men/postmenopausal women.'},
    {cat:'Hematology', stem:'Macrocytosis with neuropathy suggests:', choices:['Folate deficiency','B12 deficiency','Iron deficiency','Sideroblastic anemia'], answer:1, why:'Neurologic deficits point to B12 deficiency.'},
    {cat:'Hematology', stem:'Early iron deficiency often appears as:', choices:['Normocytic anemia with rising RDW','Macrocytic anemia','Pancytopenia','Isolated thrombocytopenia'], answer:0, why:'Anisocytosis precedes microcytosis.'},
    {cat:'Hematology', stem:'Which is TRUE about ACD?', choices:['Driven by low hepcidin','Improves with iron alone','Reduced iron availability and blunted EPO','Always macrocytic'], answer:2, why:'Hepcidin â†‘ and EPO blunted.'},
    {cat:'Hematology', stem:'Beta-thalassemia major care includes:', choices:['EPO injections only','Frequent transfusions with iron chelation','Folate restriction','No vaccines'], answer:1, why:'Transfusions + chelation; consider HSCT.'},
    {cat:'Hematology', stem:'Very low MCV with target cells and normal iron suggests:', choices:['Iron deficiency','Anemia of inflammation','Beta-thalassemia trait','Folate deficiency'], answer:2, why:'Microcytosis out of proportion; Mentzer index <13.'},
    {cat:'Hematology', stem:'Confirm B12 deficiency when B12 borderline with:', choices:['Ferritin','Methylmalonic acid','Retic count','Serum folate'], answer:1, why:'MMA rises in cellular B12 deficiency.'},
    {cat:'Hematology', stem:'Hemolysis after primaquine suggests:', choices:['G6PD deficiency','Sickle trait','Warm AIHA','PNH'], answer:0, why:'Oxidant stress triggers hemolysis in G6PD deficiency.'},
    {cat:'Hematology', stem:'Normocytic anemia + low retics + high creatinine suggests:', choices:['Iron deficiency','Anemia of CKD','Hemolysis','Acute blood loss'], answer:1, why:'CKD â†’ low EPO â†’ low retic response.'},
    {cat:'Hematology', stem:'Drug causing folate-related megaloblastosis:', choices:['Metformin','Methotrexate','Furosemide','Atorvastatin'], answer:1, why:'MTX inhibits DHFR.'},
    {cat:'Hematology', stem:'Live attenuated vaccines should generally be avoided in:', choices:['Healthy adults','Severe immunodeficiency or high-dose steroids','Pregnancy only','All elderly'], answer:1, why:'Risk of vaccine-derived infection.'},
    {cat:'Hematology', stem:'Normocytic hemolysis lab set:', choices:['Low retic, high haptoglobin','High retic, low haptoglobin, high LDH','Low LDH, normal haptoglobin','High ferritin, low LDH'], answer:1, why:'Classic hemolysis pattern.'},
    {cat:'Hematology', stem:'Sideroblastic anemia mechanism:', choices:['Globin chain defect','Impaired protoporphyrin/heme synthesis in mitochondria','Autoimmune destruction','Pure EPO deficiency'], answer:1, why:'Mitochondrial iron trapping â†’ ring sideroblasts.'},
    {cat:'Hematology', stem:'Who needs GI workup for iron deficiency?', choices:['Adolescent females','Men and postmenopausal women','Pregnant patients','Athletes only'], answer:1, why:'Assess for occult GI bleeding/malignancy.'},
    {cat:'Hematology', stem:'Best initial test to separate hemolysis vs hypoproliferation:', choices:['Peripheral smear','Reticulocyte count','Serum folate','Bone marrow biopsy'], answer:1, why:'Retic count shows marrow response.'},
    {cat:'Hematology', stem:'Key long-term complication in thalassemia major therapy:', choices:['Iron overload','Hyperkalemia','Vaccine sepsis','Copper deficiency'], answer:0, why:'Chelation prevents organ damage.'},
    {cat:'Hematology', stem:'Which is correct about folate deficiency?', choices:['Neurologic deficits common','Homocysteine normal','Often from alcoholism/malnutrition and lacks neuro findings','MMA elevated'], answer:2, why:'No neuro deficits; homocysteine â†‘; MMA normal.'},
    {cat:'Hematology', stem:'Primary mechanism producing normocytic anemia of acute blood loss (first 24â€“48h):', choices:['Iron deficiency','Hemodilution and underproduction before retic rise','Autoimmune destruction','Aplastic crisis'], answer:1, why:'Acute loss initially normocytic with low retic until marrow response.'},
    {cat:'Hematology', stem:'Risk factors for megaloblastic anemia include all EXCEPT:', choices:['Alcohol use disorder','Short gut or malabsorption','Long-term metformin + PPI use','High red meat intake'], answer:3, why:'Alcohol, malabsorption, drugs (MTX, TMP-SMX, phenytoin), vegan diet (B12), and metformin/PPI â†’ risk; high red meat lowers risk.'},
    {cat:'Hematology', stem:'Risk factor for hemolytic anemia by mechanism pair:', choices:['Prosthetic heart valve â†’ microangiopathic hemolysis','G6PD deficiency â†’ cold agglutinin disease','Clostridial sepsis â†’ aplastic anemia','Warm autoantibodies â†’ schistocytosis only'], answer:0, why:'Mechanical hemolysis occurs with valves; G6PD â†’ oxidant hemolysis; warm AIHA â†’ spherocytes.'},
    {cat:'Hematology', stem:'Key labs for normocytic anemia workup include:', choices:['Reticulocyte count, LDH, haptoglobin, bilirubin','Only ferritin','Only MCV','ESR only'], answer:0, why:'Differentiate hemolysis vs hypoproliferation; pair with iron/B12/folate if indicated.'},
    {cat:'Hematology', stem:'Sickle cell disease disease-modifying therapy that reduces vaso-occlusive crises:', choices:['Hydroxyurea','Chronic aspirin','EPO injections','Folic acid alone'], answer:0, why:'Hydroxyurea â†‘HbF, reduces crises and ACS; folate supports erythropoiesis but is not disease-modifying.'},
    {cat:'Hematology', stem:'Macrocytic anemia with normal B12/folate and elevated reticulocytes suggests:', choices:['Alcohol toxicity','Hypothyroidism','Hemolysis or hemorrhage','Copper deficiency'], answer:2, why:'Reticulocytosis from hemolysis/bleeding elevates MCV; check hemolysis labs.'},
    {cat:'Hematology', stem:'Pathophysiology of aplastic anemia involves:', choices:['Autoimmune destruction or failure of bone marrow stem cells','Iron deficiency only','Hemolysis of mature RBCs','Isolated platelet consumption'], answer:0, why:'Marrow stem cell suppression leads to pancytopenia.'},
    {cat:'Hematology', stem:'Most common anemia in children worldwide:', choices:['Iron deficiency anemia','Sickle cell disease','Aplastic anemia','Vitamin B12 deficiency'], answer:0, why:'Dietary deficiency and high demand make IDA most common.'},
    {cat:'Hematology', stem:'Why should attenuated vaccines be avoided in immunocompromised patients?', choices:['They are ineffective','They may cause severe disease from the vaccine strain','They are too expensive','They only work in children'], answer:1, why:'Immunocompromised hosts cannot control replication of live vaccines.'},
    {cat:'Hematology', stem:'Important risk factors for iron deficiency anemia in addition to adult GI loss include:', choices:[
  'High vitamin C intake and obesity',
  'Heavy menstrual bleeding, pregnancy, low dietary iron, malabsorption (e.g., celiac disease)',
  'Daily multivitamin use',
  'Hyperlipidemia and gout'
  ],  answer:1, why:'High demand (menorrhagia, pregnancy), poor intake, and malabsorption are key IDA risks beyond occult GI bleeding.'},
     {cat:'Hematology', stem:'Which combination best fits **microcytic** anemia?', choices:['Low MCV, low ferritin, high TIBC','High MCV, high MMA','Normal MCV, high retic','High MCV, neurologic signs'], answer:0, why:'Classic iron deficiency pattern.'},
  {cat:'Hematology', stem:'Earliest lab abnormality in iron deficiency:', choices:['Falling ferritin','Rising hemoglobin','High TSAT','Low RDW'], answer:0, why:'Storage iron (ferritin) drops first.'},
  {cat:'Hematology', stem:'**Anemia of chronic disease** iron study set:', choices:['Low iron, low TIBC, normal/high ferritin','Low iron, high TIBC, low ferritin','High iron, high TIBC','Low ferritin, high TSAT'], answer:0, why:'Inflammation â†‘hepcidinâ†’ iron sequestration.'},
  {cat:'Hematology', stem:'**Folate deficiency** vs **B12 deficiency** discriminator:', choices:['Both elevate MMA','Folate elevates MMA only','B12 elevates MMA; folate does not','Neither affects homocysteine'], answer:2, why:'B12â†‘MMA; folateâ€”MMA normal; both â†‘homocysteine.'},
  {cat:'Hematology', stem:'Risk factor most linked to **hemolytic** anemia:', choices:['Thiazide diuretic','Prosthetic heart valve (mechanical trauma)','High calcium diet','Omega-3 use'], answer:1, why:'Mechanical hemolysis with prosthetic valves.'},
  {cat:'Hematology', stem:'**Sickle cell** pathophysiology driver:', choices:['HbS polymerization during deoxygenation','Autoantibody RBC destruction','Iron overload only','Decreased EPO'], answer:0, why:'Polymerization â†’ rigidity â†’ vaso-occlusion.'},
  {cat:'Hematology', stem:'**Hydroxyurea** benefit in sickle cell:', choices:['Cures disease','Raises HbF and reduces crises','Eliminates need for vaccines','Eradicates splenic infarction'], answer:1, why:'Disease-modifying via â†‘HbF.'},
  {cat:'Hematology', stem:'Which drug can precipitate megaloblastosis by blocking folate metabolism?', choices:['Metformin','Methotrexate','Atorvastatin','Furosemide'], answer:1, why:'MTX inhibits DHFR.'},
  {cat:'Hematology', stem:'**Beta-thalassemia major** mainstay of therapy:', choices:['EPO only','Chronic transfusion with iron chelation Â± HSCT','Folate restriction','No vaccines'], answer:1, why:'Transfusions + chelation; curative HSCT in some.'},
  {cat:'Hematology', stem:'**Normocytic** anemia workupâ€”most useful initial discriminator:', choices:['Serum folate','Reticulocyte count','Ferritin only','MMA only'], answer:1, why:'Retic distinguishes hemolysis/hemorrhage vs underproduction.'},
  {cat:'Hematology', stem:'Lab triad most compatible with **hemolysis**:', choices:['Low LDH, high haptoglobin, low bili','High LDH, low haptoglobin, indirect hyperbilirubinemia','Low retic, high haptoglobin','High ferritin, low LDH'], answer:1, why:'Classic pattern.'},
  {cat:'Hematology', stem:'**Iron deficiency** adult with no menstrual lossesâ€”next step:', choices:['Start iron only','GI evaluation for occult bleeding','Bone marrow biopsy','Stop all NSAIDs immediately'], answer:1, why:'Men/postmenopausal women require GI workup.'},
  {cat:'Hematology', stem:'**ACD** correct statement:', choices:['Always macrocytic','Hepcidin is low','EPO response is blunted','Ferritin always low'], answer:2, why:'Inflammation blunts EPO and sequesters iron.'},
  {cat:'Hematology', stem:'**G6PD** deficiency hemolysis is triggered by:', choices:['Cold weather','Primaquine or fava beans (oxidant stress)','Thiazide diuretics','Folic acid'], answer:1, why:'Oxidant stress â†’ episodic hemolysis.'},
  {cat:'Hematology', stem:'Risk set for **megaloblastic** anemia:', choices:['Alcohol use disorder, malabsorption, MTX/TMP-SMX, vegan diet','High meat intake, strength training','Thiazides, beta-blockers','Calcium supplements'], answer:0, why:'Classics for folate/B12 deficiency.'},

  ],
  'Cardiovascular': [
    {cat:'Cardio', stem:'Initial event in atherosclerosis is:', choices:['Calcification of fibrous cap','Endothelial dysfunction with LDL infiltration','Platelet plug formation','Media necrosis'], answer:1, why:'Endothelial injury permits LDL entry/oxidation and monocyte recruitment.'},
    {cat:'Cardio', stem:'Most directly atherogenic lipoprotein:', choices:['HDL','LDL','Chylomicrons','ApoA1'], answer:1, why:'LDL deposits cholesterol in plaques.'},
    {cat:'Cardio', stem:'Desirable total cholesterol:', choices:['<180 mg/dL','<200 mg/dL','<220 mg/dL','<240 mg/dL'], answer:1, why:'Standard adult threshold.'},
    {cat:'Cardio', stem:'Nonmodifiable CAD risk factor:', choices:['Hypertension','Smoking','Family history of premature ASCVD','Diabetes'], answer:2, why:'Family history, age, sex.'},
    {cat:'Cardio', stem:'HFrEF defined by:', choices:['EF â‰¥50%','EF â‰¤40% with systolic dysfunction','High-output failure','Right HF only'], answer:1, why:'HFrEF = EF â‰¤40%.'},
    {cat:'Cardio', stem:'Murmur of aortic stenosis:', choices:['Holosystolic at apex to axilla','Early diastolic at LSB','Harsh crescendoâ€“decrescendo at RUSB to carotids','Low-pitched diastolic rumble with opening snap'], answer:2, why:'Classic AS.'},
    {cat:'Cardio', stem:'Wide pulse pressure with blowing early diastolic murmur suggests:', choices:['Aortic regurgitation','Mitral stenosis','Tricuspid regurgitation','Pulmonic stenosis'], answer:0, why:'AR creates bounding pulses and early diastolic decrescendo murmur.'},
    {cat:'Cardio', stem:'Most common cause of mitral stenosis worldwide:', choices:['Degenerative calcification','Rheumatic heart disease','Endocarditis in IVDU','Congenital prolapse'], answer:1, why:'Rheumatic cause is classic.'},
    {cat:'Cardio', stem:'Guideline-directed therapy for Stage C HFrEF:', choices:['ACEi + thiazide + nitrate + digoxin','ARNI/ACEi/ARB + Î²-blocker + MRA + SGLT2 inhibitor','ARB + CCB + statin + loop','ACEi + hydralazine alone'], answer:1, why:'The four pillars improve outcomes.'},
    {cat:'Cardio', stem:'Purpose of NYHA functional class:', choices:['Stage structural disease only','Describe symptom limitation and exercise tolerance','Replace ACC/AHA staging','Define transplant need'], answer:1, why:'Grades Iâ€“IV symptoms; complements ACC/AHA.'},
    {cat:'Cardio', stem:'Right-sided HF hallmark:', choices:['Orthopnea and rales','JVD, hepatomegaly, peripheral edema','S3 only','Hemoptysis'], answer:1, why:'Systemic venous congestion.'},
    {cat:'Cardio', stem:'Primary dyslipidemia example:', choices:['Hypothyroidism-induced hypercholesterolemia','Familial hypercholesterolemia (LDLR defect)','Nephrotic syndrome','Cholestasis'], answer:1, why:'Monogenic LDLR defect.'},
    {cat:'Cardio', stem:'Secondary dyslipidemia cause:', choices:['ApoB mutation','PCSK9 gain-of-function','Diabetes mellitus','LDLR deletion'], answer:2, why:'Common metabolic cause.'},
    {cat:'Cardio', stem:'S3 heart sound suggests:', choices:['AS with LVH','HFrEF with volume overload/dilated ventricle','HCM','MS'], answer:1, why:'Rapid filling into dilated ventricle.'},
    {cat:'Cardio', stem:'HFpEF key abnormality:', choices:['Impaired contractility','Impaired relaxation/increased stiffness','Valve regurgitation','RV infarction'], answer:1, why:'Diastolic dysfunction with preserved EF.'},
    {cat:'Cardio', stem:'Murmur radiating to axilla is:', choices:['Mitral regurgitation','Tricuspid regurgitation','Aortic stenosis','Pulmonic stenosis'], answer:0, why:'MR at apex â†’ axilla.'},
    {cat:'Cardio', stem:'Stage B HF includes:', choices:['At risk only','Structural heart disease without symptoms','Structural disease with symptoms','Refractory HF'], answer:1, why:'B = structural disease, no symptoms.'},
    {cat:'Cardio', stem:'Intervention lowering intraglomerular pressure/albuminuria in CKD with HF:', choices:['Loop diuretic','ACE inhibitor','Nitrate','Digoxin'], answer:1, why:'ACEi/ARB dilate efferent arteriole.'},
    {cat:'Cardio', stem:'Smoking contributes to CAD primarily by:', choices:['Raising HDL','Reducing oxidative stress','Endothelial injury and prothrombotic effects','Lowering fibrinogen'], answer:2, why:'Promotes endothelial dysfunction and thrombosis.'},
    {cat:'Cardio', stem:'Lipid pattern in nephrotic syndrome:', choices:['Low TG','Marked hypertriglyceridemia and â†‘LDL','Very high HDL','Isolated low LDL'], answer:1, why:'Increased hepatic lipoprotein synthesis.'},
    {cat:'Cardio', stem:'Bicuspid aortic valve risk:', choices:['Mitral stenosis','Aortic stenosis and aortopathy','Tricuspid atresia','Pulmonic regurgitation'], answer:1, why:'Early calcific AS + aortic dilation risk.'},
    {cat:'Cardio', stem:'Hydralazine/isosorbide dinitrate mortality benefit especially in:', choices:['HFpEF','Black patients with HFrEF on optimal therapy or ACEi intolerance','AS','CKD5 only'], answer:1, why:'Evidence-based add-on in Black patients or ACEi-intolerant.'},
    {cat:'Cardio', stem:'Ivabradine is considered in HFrEF with:', choices:['AFib','Sinus rhythm with HR â‰¥70 on max Î²-blocker','Bradycardia','Severe hypotension'], answer:1, why:'If-channel inhibitor lowers HR in sinus rhythm.'},
    {cat:'Cardio', stem:'Correct HDL vs LDL statement:', choices:['HDL promotes cholesterol efflux from macrophages','LDL removes cholesterol from plaques','HDL is always pro-inflammatory','LDL has no role in atherogenesis'], answer:0, why:'HDL supports reverse cholesterol transport.'},
    {cat:'Cardio', stem:'Major modifiable risk factor set for heart failure development includes:', choices:['Age, male sex, family history','Hypertension, diabetes, CAD, obesity, smoking','Marfan syndrome, bicuspid valve','Rheumatic fever only'], answer:1, why:'HTN/CAD/DM/obesity/smoking drive HF incidence.'},
    {cat:'Cardio', stem:'ACC/AHA Stage B heart failure recommended pharmacotherapy when appropriate:', choices:['No meds until symptoms','ACEi/ARB (or ARNI if post-MI LV dysfunction) plus evidence-based Î²-blocker in LV systolic dysfunction','Loop diuretic only','Ivabradine'], answer:1, why:'Stage B = structural disease without symptoms; treat underlying causes and start neurohormonal blockade in LV dysfunction or post-MI.'},
    {cat:'Cardio', stem:'Left-sided HF pathophysiology dominant mechanism:', choices:['Systemic venous congestion','Pulmonary venous congestion leading to dyspnea/orthopnea','Portal hypertension','Right-to-left shunt'], answer:1, why:'Elevated LVEDP â†’ pulmonary congestion symptoms.'},
    {cat:'Cardio', stem:'Risk factor for degenerative aortic stenosis:', choices:['Young age','Bicuspid valve or long-standing hyperlipidemia/CKD','Mitral valve prolapse','Peripartum state'], answer:1, why:'Bicuspid valve accelerates calcific AS; CKD and lipids contribute.'},
    {cat:'Cardio', stem:'Ejection fraction thresholds typically used to define HF categories:', choices:['HFrEF â‰¤40%, HFmrEF 41â€“49%, HFpEF â‰¥50%','HFrEF â‰¤30%, HFpEF >30%','HFpEF â‰¤40% only','No EF categories exist'], answer:0, why:'Standard EF categories used in guidelines.'},
    {cat:'Cardio', stem:'Key difference between ACC/AHA HF stages and NYHA functional classes:', choices:['ACC/AHA focus on symptoms; NYHA focuses on structure','NYHA is symptom-based, ACC/AHA is progressive stage-based (risk â†’ structural â†’ symptoms â†’ refractory)','They are identical','Both only apply to HFrEF'], answer:1, why:'NYHA grades symptoms; ACC/AHA covers disease progression and risk.'},
    {cat:'Cardio', stem:'Stage B HF pharmacology is aimed at:', choices:['Relieving fluid overload only','Preventing symptomatic progression with ACEi/ARB/Î²-blockers when indicated','Using ICD immediately in all','Nitrates and diuretics first line'], answer:1, why:'Stage B focuses on prevention in structural disease.'},
    {cat:'Cardio', stem:'Which murmur is diastolic, low-pitched, and associated with an opening snap?', choices:['Aortic stenosis','Mitral stenosis','Mitral regurgitation','Aortic regurgitation'], answer:1, why:'MS classic murmur: diastolic rumble with opening snap.'},
    {cat:'Cardio', stem:'Which patients are ACC/AHA Stage A for heart failure?', choices:['Structural heart disease without symptoms','Refractory symptoms at rest','At risk for HF but without structural disease or symptoms (e.g., HTN, DM)','Structural disease with prior/current symptoms'], answer:2, why:'Stage A = risk only; Stage B = structural no symptoms; Stage C = structural + symptoms; Stage D = refractory.'},
    {cat:'Cardio', stem:'ACC/AHA Stage D heart failure is best described as:', choices:['At risk only','Refractory HF requiring advanced therapies (inotropes, LVAD, transplant, palliative)','Structural disease without symptoms','New-onset hypertension'], answer:1, why:'Stage D = advanced/refractory HF.'},
    {cat:'Cardio', stem:'Risk factors for degenerative calcific aortic stenosis include:', choices:['Low LDL and female sex only','Bicuspid aortic valve, age, hyperlipidemia, CKD, smoking','Rheumatic fever only','Acute myocarditis'], answer:1, why:'Bicuspid anatomy accelerates calcification; atherosclerotic risks (lipids, smoking, CKD) contribute.'},
    {cat:'Cardio', stem:'Which total cholesterol thresholds are correct for adults?', choices:[
  'Normal <180; Borderline 180â€“219; High â‰¥220 mg/dL',
  'Normal <200; Borderline 200â€“239; High â‰¥240 mg/dL',
  'Normal <220; Borderline 220â€“259; High â‰¥260 mg/dL',
  'Normal <190; Borderline 190â€“229; High â‰¥230 mg/dL'
], answer:1, why:'Standard adult cut points: desirable <200 mg/dL; borderline high 200â€“239; high â‰¥240.'},

{cat:'Cardio', stem:'Most common cause of chronic primary mitral regurgitation in high-income countries:', choices:[
  'Ischemic papillary muscle dysfunction',
  'Myxomatous degeneration/mitral valve prolapse',
  'Rheumatic carditis',
  'Congenital cleft mitral valve'
], answer:1, why:'MVP/myxomatous degeneration is the leading chronic primary MR cause; ischemic MR is typically secondary/functional.'},

{cat:'Cardio', stem:'Typical etiologies of chronic aortic regurgitation include:', choices:[
  'Pulmonic stenosis and ASD',
  'Bicuspid aortic valve and aortic root dilation (e.g., hypertension, Marfan) Â± prior endocarditis',
  'Tricuspid atresia and coarctation',
  'Mitral annular calcification alone'
], answer:1, why:'AR commonly arises from leaflet disease (bicuspid, endocarditis) or root dilation (HTN, connective-tissue disease).'},
 {cat:'Cardio', stem:'Adult total cholesterol classification is best summarized as:', choices:[
    'Normal <180; Borderline 180â€“219; High â‰¥220 mg/dL',
    'Desirable <200; Borderline high 200â€“239; High â‰¥240 mg/dL',
    'Desirable <220; Borderline high 220â€“259; High â‰¥260 mg/dL',
    'Desirable <190; Borderline high 190â€“229; High â‰¥230 mg/dL'
  ], answer:1, why:'Standard adult cut points: desirable <200 mg/dL; borderline high 200â€“239; high â‰¥240.'},

  {cat:'Cardio', stem:'Which is a **primary (genetic)** cause of dyslipidemia?', choices:[
    'Hypothyroidism',
    'Nephrotic syndrome',
    'Familial hypercholesterolemia (LDLR/ApoB/PCSK9 defects)',
    'Excess alcohol intake'
  ], answer:2, why:'Primary = inherited disorders such as familial hypercholesterolemia; others are secondary/acquired.'},

  {cat:'Cardio', stem:'Which is a **secondary (acquired)** cause of dyslipidemia?', choices:[
    'ApoB mutation',
    'PCSK9 gain-of-function',
    'Diabetes/insulin resistance',
    'LDLR truncation'
  ], answer:2, why:'Insulin resistance, hypothyroidism, CKD/nephrotic syndrome, cholestasis, alcohol, and certain meds are common secondary causes.'},

  {cat:'Cardio', stem:'Pathophysiology of **aortic stenosis** is best described as:', choices:[
    'Volume overload â†’ eccentric LV hypertrophy',
    'Pressure overload from a fixed outflow obstruction â†’ concentric LV hypertrophy',
    'Diastolic regurgitant flow â†’ wide pulse pressure',
    'LA pressure elevation from inflow obstruction â†’ pulmonary edema'
  ], answer:1, why:'AS creates pressure overload and concentric LVH; symptoms include angina, syncope, dyspnea.'},

  {cat:'Cardio', stem:'**Aortic regurgitation** primarily causes which ventricular change?', choices:[
    'Concentric LV hypertrophy due to pressure load',
    'Eccentric LV hypertrophy due to volume overload',
    'RV dilation only',
    'No structural change'
  ], answer:1, why:'Diastolic backflow produces chronic LV volume overload â†’ eccentric LV remodeling and wide pulse pressure.'},

  {cat:'Cardio', stem:'**Mitral stenosis** hemodynamics are dominated by:', choices:[
    'Increased LA pressure with pulmonary congestion and AF risk',
    'Reduced LV preload with bounding pulses',
    'Fixed RV outflow obstruction',
    'Acute papillary muscle rupture'
  ], answer:0, why:'Rheumatic MS â†’ elevated LA pressure â†’ dyspnea, hemoptysis, AF; diastolic rumble with opening snap.'},

  {cat:'Cardio', stem:'**Mitral regurgitation** pathophysiology leads to:', choices:[
    'Solely pressure overload of LV',
    'Systolic backflow â†’ LA/LV volume overload and eventual pulmonary HTN',
    'Immediate cardiogenic shock in all patients',
    'No effect on LA size'
  ], answer:1, why:'Chronic MR causes volume overload of LA/LV, LA dilation, and later pulmonary hypertension.'},
     {cat:'Cardio', stem:'Earliest step in atherogenesis:', choices:['Foam cell formation without LDL','Endothelial dysfunction with LDL infiltration/oxidation','Calcification first','Media necrosis first'], answer:1, why:'Endothelial injury â†’ LDL entry/oxidation â†’ monocytes â†’ foam cells.'},
  {cat:'Cardio', stem:'**Primary** dyslipidemia example:', choices:['Familial hypercholesterolemia (LDLR/ApoB/PCSK9)','Hypothyroidism','Nephrotic syndrome','Alcohol excess'], answer:0, why:'Inherited lipid disorder = primary.'},
  {cat:'Cardio', stem:'**Secondary** dyslipidemia cause:', choices:['LDLR mutation','PCSK9 GoF','Diabetes/insulin resistance','ApoB truncation'], answer:2, why:'Metabolic/acquired etiologies are secondary.'},
  {cat:'Cardio', stem:'**HFrEF** hallmark:', choices:['EF â‰¥50%','EF â‰¤40% with systolic dysfunction','Right HF only','High-output HF only'], answer:1, why:'Definition of HFrEF.'},
  {cat:'Cardio', stem:'**HFpEF** pathophysiology:', choices:['Impaired relaxation/increased stiffness with preserved EF','Severe MR only','Isolated RV infarction','Pure valve stenosis'], answer:0, why:'Diastolic dysfunction with preserved EF.'},
  {cat:'Cardio', stem:'**ACC/AHA Stage B** heart failure means:', choices:['At risk only','Structural heart disease without symptoms','Structural + symptoms','Refractory'], answer:1, why:'Stage B = structural, no symptoms.'},
  {cat:'Cardio', stem:'Guideline â€œfour pillarsâ€ for **HFrEF Stage C**:', choices:['ACEi + thiazide + nitrate + digoxin','ARNI/ACEi/ARB + Î²-blocker + MRA + SGLT2 inhibitor','ARB + CCB + statin + loop','Hydralazine alone'], answer:1, why:'Mortality-benefit therapies.'},
  {cat:'Cardio', stem:'**Aortic stenosis** classic murmur:', choices:['Holosystolic to axilla','Harsh crescendo-decrescendo at RUSB radiating to carotids','Early diastolic blowing at LSB','Low-pitched diastolic rumble with opening snap'], answer:1, why:'Classic AS finding.'},
  {cat:'Cardio', stem:'**Aortic regurgitation** hemodynamics:', choices:['Narrow pulse pressure','Wide pulse pressure with bounding pulses','No change in LV size','RV volume overload'], answer:1, why:'Diastolic backflow â†’ wide pulse pressure.'},
  {cat:'Cardio', stem:'**Mitral stenosis** murmur:', choices:['Systolic ejection at RUSB','Holosystolic at apex','Diastolic rumble with opening snap (apex)','Early diastolic at LSB'], answer:2, why:'Rheumatic MS classic.'},
  {cat:'Cardio', stem:'**Mitral regurgitation** consequence over time:', choices:['Pure pressure overload','LA/LV volume overload â†’ LA dilation, pulmonary HTN','No LA change','Only RV strain'], answer:1, why:'Chronic MR = volume overload.'},
  {cat:'Cardio', stem:'**NYHA** functional class role:', choices:['Defines structural stage','Grades symptom limitation (Iâ€“IV)','Replaces ACC/AHA','Used only for HFrEF'], answer:1, why:'Symptom-based scale.'},
  {cat:'Cardio', stem:'**Total cholesterol** adult thresholds:', choices:['Normal <180; Borderline 180â€“219; High â‰¥220','Desirable <200; Borderline 200â€“239; High â‰¥240','Desirable <220; Borderline 220â€“259; High â‰¥260','Desirable <190; Borderline 190â€“229; High â‰¥230'], answer:1, why:'Standard cut points.'},
  {cat:'Cardio', stem:'**Bicuspid aortic valve** risk includes:', choices:['Mitral stenosis','Early calcific AS and aortopathy','Tricuspid atresia','Pulmonic regurgitation only'], answer:1, why:'Accelerated AS + aortic dilation.'},
  {cat:'Cardio', stem:'**S3** suggests:', choices:['Stiff ventricle only','HFrEF with volume overload/dilated ventricle','HCM','MS'], answer:1, why:'Early diastolic filling into dilated LV.'},
  ],
  'Pulmonary': [
    {cat:'Pulmonary', stem:'Obstructive PFT pattern:', choices:['Low TLC with normal/high FEV1/FVC','Low FEV1 and FEV1/FVC <0.70 with air trapping','Normal FEV1/FVC with low DLCO only','High TLC with high FEV1/FVC'], answer:1, why:'Ratio falls; RV/TLC often â†‘.'},
    {cat:'Pulmonary', stem:'Restrictive hallmark on PFT:', choices:['Low TLC with normal/high FEV1/FVC','Low FEV1/FVC','High TLC','Increased RV only'], answer:0, why:'Reduced expansion â†’ low TLC; ratio normal/high.'},
    {cat:'Pulmonary', stem:'Chronic bronchitis pathophysiology:', choices:['Loss of alveolar septa only','Goblet cell hyperplasia with mucus hypersecretion and airway inflammation','Pulmonary vascular pruning','AAT deficiency exclusively'], answer:1, why:'Mucus and inflammation dominate.'},
    {cat:'Pulmonary', stem:'Centriacinar emphysema association:', choices:['Non-smokers','AAT deficiency lower lobes','Smoking upper lobes','TB'], answer:2, why:'Smoking â†’ centriacinar upper lobes.'},
    {cat:'Pulmonary', stem:'Acute asthma management:', choices:['SABA + systemic steroids Â± ipratropium','ICS only','Antibiotics + diuretics','Theophylline'], answer:0, why:'Rapid bronchodilation + inflammation control.'},
    {cat:'Pulmonary', stem:'Asthma patient education includes all EXCEPT:', choices:['Inhaler technique/spacer','Trigger identification/avoidance','Written action plan','Stop all activity'], answer:3, why:'Control enables normal activity.'},
    {cat:'Pulmonary', stem:'ILD exam findings:', choices:['Wheezes only','Bibasilar â€œVelcroâ€ crackles and digital clubbing (late)','Loud P2 always','Stridor'], answer:1, why:'Fine crackles + clubbing in advanced disease.'},
    {cat:'Pulmonary', stem:'Mechanics of quiet breathing rely most on:', choices:['Positive intrathoracic pressure','Diaphragmatic descent creating negative pressure','Accessory muscles at rest','Glottic closure'], answer:1, why:'Diaphragm-driven negative pressure.'},
    {cat:'Pulmonary', stem:'Asthma hallmark physiologic feature:', choices:['Fixed obstruction','Reversible airflow limitation and hyperresponsiveness','Restrictive defect','Primary diffusion impairment only'], answer:1, why:'Typically reversible.'},
    {cat:'Pulmonary', stem:'Emphysema physiologic change:', choices:['Increased elastic recoil','Loss of elastic recoil with dynamic airway collapse','Bronchiectasis','Pulmonary edema'], answer:1, why:'Alveolar wall destruction decreases recoil.'},
    {cat:'Pulmonary', stem:'ICS/LABA role in COPD:', choices:['Cure disease','Reduce exacerbations in frequent exacerbators or eosinophilic phenotype','Normalize FEV1','Prevent lung cancer'], answer:1, why:'Reduces exacerbations in selected patients.'},
    {cat:'Pulmonary', stem:'AAT deficiency emphysema pattern:', choices:['Upper lobes, centriacinar','Lower lobes, panacinar','Diffuse bronchiectasis only','Apical bullae exclusively'], answer:1, why:'Panacinar lower-lobe predominant.'},
    {cat:'Pulmonary', stem:'Metric distinguishing obstruction vs restriction:', choices:['TLC primarily','FEV1/FVC ratio primarily','DLCO only','RV only'], answer:1, why:'Ratio <0.70 = obstruction; low TLC = restriction.'},
    {cat:'Pulmonary', stem:'Adjunct in life-threatening asthma after SABA/steroids Â± ipratropium:', choices:['Magnesium sulfate IV','Antibiotics immediately','Theophylline infusion','Diuretics'], answer:0, why:'Bronchial smooth muscle relaxation.'},
    {cat:'Pulmonary', stem:'Pathophysiology of interstitial lung disease (ILD):', choices:['Proximal airway mucus plugging only','Inflammation â†’ fibroblast activation â†’ extracellular matrix deposition â†’ decreased compliance and impaired gas exchange','Loss of Î±1-antitrypsin causing alveolar destruction','Pure pulmonary vascular disease'], answer:1, why:'Fibrosing interstitial process reduces compliance and DLCO.'},
    {cat:'Pulmonary', stem:'Chronic bronchitis diagnostic hallmark:', choices:['Productive cough â‰¥3 months/year for â‰¥2 consecutive years','DLCO severely reduced always','Apical bullae on CT','Immediate reversibility with bronchodilator'], answer:0, why:'Clinical definition; often normal or mildly â†“DLCO.'},
    {cat:'Pulmonary', stem:'Emphysema treatment cornerstone improving survival:', choices:['ICS alone','Long-term oxygen therapy in chronic hypoxemia','Theophylline','Antibiotics'], answer:1, why:'LTOT improves survival in COPD with chronic hypoxemia.'},
    {cat:'Pulmonary', stem:'Controller therapy for persistent asthma per stepwise approach:', choices:['SABA only','Low-dose ICS (or ICS-formoterol as maintenance and reliever)','Leukotriene antagonist alone for all','Oral steroids chronically'], answer:1, why:'ICS-based control is first-line for persistent asthma.'},
    {cat:'Pulmonary', stem:'Key patient education point for asthma management:', choices:['Avoid all physical activity','Understand triggers, proper inhaler technique, and follow a written action plan','Rely only on oral steroids','Discontinue all controller meds once asymptomatic'], answer:1, why:'Self-management with education improves outcomes.'},
    {cat:'Pulmonary', stem:'Panacinar emphysema is classically associated with:', choices:['Smoking, upper lobes','Alpha-1 antitrypsin deficiency, lower lobes','Asthma','Sarcoidosis'], answer:1, why:'AAT deficiency â†’ panacinar, lower lobe.'},
    {cat:'Pulmonary', stem:'Restrictive ILD pattern vs obstructive asthma pattern on spirometry:', choices:['ILD = â†“TLC with preserved/high FEV1/FVC; Asthma = â†“FEV1 and â†“FEV1/FVC ratio','Both show â†“FEV1/FVC','Both show â†‘TLC','ILD shows increased DLCO'], answer:0, why:'Obstruction lowers ratio; restriction preserves ratio with low TLC.'},
    {cat:'Pulmonary', stem:'Classic signs/symptoms of chronic bronchitis include:', choices:['Nonproductive cough, weight loss, hyperresonance','Productive cough â‰¥3 months/year for â‰¥2 years, wheeze, cyanosis tendency','Hemoptysis, clubbing, pleuritic chest pain only','Sudden onset dyspnea with clear lungs'], answer:1, why:'Clinical definition + common findings.'},
    {cat:'Pulmonary', stem:'Outpatient chronic bronchitis (COPD) maintenance priorities include:', choices:['Immediate long-term steroids alone','Smoking cessation, vaccinations, bronchodilators (LAMA/LABA Â± ICS by phenotype), pulmonary rehab','Antibiotics daily','SABA only'], answer:1, why:'Evidence-based pillars of COPD care.'}, 
    {cat:'Pulmonary', stem:'Classic clinical differences: emphysema vs chronic bronchitis phenotype', choices:[
  'Emphysema: chronic purulent cough, cyanosis; CB: cachectic with pursed-lip breathing',
  'Emphysema: exertional dyspnea, weight loss, barrel chest, pursed-lip breathing; CB: chronic productive cough â‰¥3 mo/yr Ã—2y, wheeze, cyanosis tendency',
  'Emphysema: recurrent infections with copious sputum; CB: minimal sputum',
  'They are clinically indistinguishable'
], answer:1, why:'Traditional â€œpink pufferâ€ (emphysema) vs â€œblue bloaterâ€ (chronic bronchitis) phenotypes highlight dyspnea/cachexia vs cough/sputum/cyanosis.'},
    {cat:'Pulmonary', stem:'**Mechanics of breathing** (quiet inspiration) primarily depend on:', choices:['Accessory muscles','Diaphragmatic descent creating negative intrathoracic pressure','Active exhalation','Glottic closure'], answer:1, why:'Diaphragm is main inspiratory muscle at rest.'},
  {cat:'Pulmonary', stem:'Spirometry hallmark of **obstruction**:', choices:['FEV1/FVC normal or high','FEV1/FVC <0.70','TLC very low always','DLCO always increased'], answer:1, why:'Reduced ratio defines obstruction.'},
  {cat:'Pulmonary', stem:'Spirometry hallmark of **restriction**:', choices:['Low TLC with normal/high FEV1/FVC','Low FEV1/FVC','High TLC','RV high only'], answer:0, why:'Reduced expansion with preserved ratio.'},
  {cat:'Pulmonary', stem:'**Chronic bronchitis** pathophysiology:', choices:['AAT deficiency only','Goblet cell hyperplasia, mucus hypersecretion, airway inflammation','Diffuse alveolar destruction only','Vasculopathy predominantly'], answer:1, why:'Mucus + inflammation dominate CB.'},
  {cat:'Pulmonary', stem:'**Emphysema** type tied to smoking:', choices:['Panacinar lower lobe','Centrilobular upper lobe','Paraseptal only lower lobe','Basilar bullae only'], answer:1, why:'Smoking â†’ centriacinar, apical predominance.'},
  {cat:'Pulmonary', stem:'**AAT deficiency** pattern:', choices:['Upper lobe centriacinar','Lower lobe panacinar','Isolated bronchiectasis','Asthma only'], answer:1, why:'Panacinar lower-lobe predominant.'},
  {cat:'Pulmonary', stem:'**Asthma** hallmark:', choices:['Fixed obstruction','Reversible airflow limitation and hyperresponsiveness','Pure diffusion defect','Primary pulmonary vascular disease'], answer:1, why:'Typically reversible with bronchodilators.'},
  {cat:'Pulmonary', stem:'**Acute asthma** first-line management:', choices:['SABA + systemic steroids Â± ipratropium','ICS alone','Antibiotics','Diuretics'], answer:0, why:'Rapid bronchodilation + inflammation control.'},
  {cat:'Pulmonary', stem:'**ILD** pathophysiology:', choices:['Mucus plugging only','Inflammation â†’ fibroblast activation â†’ ECM deposition â†’ â†“compliance and â†“DLCO','Alpha-1 antitrypsin loss','Pulmonary edema only'], answer:1, why:'Fibrosing interstitial process.'},
  {cat:'Pulmonary', stem:'**ILD** physical exam:', choices:['Diffuse wheezes only','Bibasilar â€œVelcroâ€ crackles Â± clubbing','Stridor','Loud P2 always'], answer:1, why:'Fine crackles; clubbing in advanced disease.'},
  {cat:'Pulmonary', stem:'**Patient education** in asthma includes:', choices:['Avoid all activity','Written action plan, trigger avoidance, inhaler technique/spacer','Rely on oral steroids chronically','Stop controllers when asymptomatic'], answer:1, why:'Education improves control/outcomes.'},
  {cat:'Pulmonary', stem:'**Magnesium sulfate IV** in life-threatening asthma works by:', choices:['Mast-cell stabilization only','Bronchial smooth muscle relaxation (calcium antagonism)','Mucolysis','Leukotriene receptor blockade'], answer:1, why:'Smooth muscle relaxant effect.'},
  {cat:'Pulmonary', stem:'**Chronic bronchitis** clinical definition:', choices:['Cough any time for 1 month','Productive cough â‰¥3 months/year for â‰¥2 consecutive years','Any cough with wheeze','Daily cough for 1 week'], answer:1, why:'Standard clinical criterion.'},
  {cat:'Pulmonary', stem:'**Emphysema** survival-improving therapy in chronic hypoxemia:', choices:['Theophylline','Long-term oxygen therapy','ICS monotherapy','Macrolide daily'], answer:1, why:'LTOT improves survival.'},
  {cat:'Pulmonary', stem:'**Obstructive vs restrictive** key metric:', choices:['TLC only','FEV1/FVC ratio primarily','RV only','DLCO only'], answer:1, why:'Ratio â†“ in obstruction; TLC â†“ in restriction.'},

  ],
  'Renal & Urinary': [
    {cat:'Renal', stem:'Uncomplicated cystitis presentation:', choices:['Fever, flank pain, CVA tenderness','Dysuria, frequency, urgency without systemic toxicity','Gross hematuria only','Urinary retention'], answer:1, why:'Irritative voiding symptoms; afebrile typically.'},
    {cat:'Renal', stem:'Complicated UTI definition includes all EXCEPT:', choices:['Male sex','Pregnancy','Neurogenic bladder/catheter','Otherwise healthy nonpregnant woman'], answer:3, why:'Healthy nonpregnant female without abnormalities = uncomplicated.'},
    {cat:'Renal', stem:'Acute pyelonephritis hallmark:', choices:['Bland UA with no pyuria','WBC casts and CVA tenderness','Only microscopic hematuria','Normal temperature'], answer:1, why:'Fever, flank pain, pyuria/WBC casts.'},
    {cat:'Renal', stem:'BPH pathophysiology:', choices:['Estrogen excess only','DHT-mediated stromal/epithelial hyperplasia causing outlet obstruction','Autoimmune prostatitis','Congenital stricture'], answer:1, why:'DHT stimulates transitional zone growth.'},
    {cat:'Renal', stem:'First-line drug class for rapid LUTS relief in BPH:', choices:['5-ARI','Alpha-1 blockers','Antibiotics','Loop diuretics'], answer:1, why:'Alpha-blockers relax smooth muscle quickly.'},
    {cat:'Renal', stem:'Renal colic pain radiation:', choices:['Chest to jaw','Flank to groin','Back to left arm','RUQ to shoulder'], answer:1, why:'Ureteral stone path.'},
    {cat:'Renal', stem:'Urge incontinence is primarily due to:', choices:['Outlet obstruction','Detrusor overactivity','Fistula','Overflow only'], answer:1, why:'Overactive bladder with urgency Â± leakage.'},
    {cat:'Renal', stem:'AKI with BUN:Cr >20 and FeNa <1% suggests:', choices:['Intrinsic ATN','Prerenal azotemia','Post-renal obstruction','Rhabdomyolysis'], answer:1, why:'Hypoperfusion with intact parenchyma.'},
    {cat:'Renal', stem:'Intrinsic AKI (ATN) typically shows:', choices:['FeNa <1%','FeNa >2% with muddy brown casts','No casts','Only hematuria'], answer:1, why:'Granular casts; impaired reabsorption.'},
    {cat:'Renal', stem:'CKD is diagnosed when abnormalities persist for:', choices:['>1 week','>1 month','>3 months','>12 months'], answer:2, why:'KDIGO definition.'},
    {cat:'Renal', stem:'eGFR category for stage G4 CKD:', choices:['â‰¥90','60â€“89','30â€“44','15â€“29'], answer:3, why:'G4 = 15â€“29 mL/min/1.73mÂ².'},
    {cat:'Renal', stem:'ACE inhibitors slow CKD primarily by:', choices:['Constriction of afferent arteriole','Dilation of efferent arteriole reducing intraglomerular pressure and albuminuria','Increasing aldosterone','Raising intraglomerular pressure'], answer:1, why:'Efferent dilation lowers filtration pressure.'},
    {cat:'Renal', stem:'Uremic syndrome hematologic effect:', choices:['Polycythemia','Platelet dysfunction with bleeding tendency','Leukemoid reaction','Marked eosinophilia'], answer:1, why:'Uremia impairs platelet function.'},
    {cat:'Renal', stem:'Vitamin D activation failure in CKD leads to:', choices:['Hypercalcemia with low PTH','Hypocalcemia and secondary hyperparathyroidism','Normal bone metabolism','Hypermagnesemia causing tetany'], answer:1, why:'â†“1,25-(OH)2D â†’ â†“Ca absorption â†’ â†‘PTH.'},
    {cat:'Renal', stem:'Common cause of dyslipidemia in CKD:', choices:['Increased HDL function','Inflammation/insulin resistance â†’ â†‘TG-rich lipoproteins','Complete absence of LDL','High bile acid loss'], answer:1, why:'CKD alters lipoprotein metabolism.'},
    {cat:'Renal', stem:'Indication to start urgent RRT in AKI includes:', choices:['Mild anemia','Metabolic acidosis or life-threatening hyperkalemia (AEIOU)','Asymptomatic bacteriuria','Mild hypokalemia'], answer:1, why:'AEIOU: Acidosis, Electrolytes, Intoxications, Overload, Uremia.'},
    {cat:'Renal', stem:'Azotemia is defined as:', choices:['Uremic symptoms with pericarditis','Elevated BUN/creatinine due to reduced GFR or increased production','Proteinuria >3.5 g/day','Hematuria with casts'], answer:1, why:'Lab elevation of nitrogenous wastes; uremia implies symptoms.'},
    {cat:'Renal', stem:'Pathophysiology of uncomplicated cystitis most commonly involves:', choices:['Hematogenous spread of S. aureus','Ascending infection by uropathogens (e.g., E. coli) via urethra','Viral invasion of renal parenchyma','Transplant rejection'], answer:1, why:'Most UTIs are ascending E. coli from periurethral area.'},
    {cat:'Renal', stem:'Acute pyelonephritis pathophysiology best described as:', choices:['Immune complex glomerulonephritis','Ascending infection with bacterial invasion of renal parenchyma and collecting system','Prerenal azotemia','Interstitial nephritis from drugs only'], answer:1, why:'Upper tract infection with systemic features and WBC casts.'},
    {cat:'Renal', stem:'Risk factors for BPH include:', choices:['Age <30 and strenuous exercise','Increasing age, androgens, family history, metabolic syndrome/obesity','Prior UTIs only','Low testosterone levels'], answer:1, why:'Prevalence rises with age; DHT-driven growth; metabolic factors contribute.'},
    {cat:'Renal', stem:'Differentiate functional vs urge incontinence:', choices:['Functional: detrusor overactivity; Urge: mobility/cognition barrier','Functional: mobility/cognition barrier; Urge: detrusor overactivity with sudden urge','Both are outlet obstruction','Both due to fistula'], answer:1, why:'Functional = canâ€™t reach toilet; urge = overactive detrusor.'},
    {cat:'Renal', stem:'Risk factor set for prerenal AKI:', choices:['NSAID/ACEi/ARB use with hypovolemia, heart failure, cirrhosis','Aminoglycoside toxicity only','Obstructing stone only','Autoimmune vasculitis'], answer:0, why:'Renal hypoperfusion from volume loss or low effective arterial volume; meds alter glomerular tone.'},
    {cat:'Renal', stem:'Risk factor set for intrinsic AKI (ATN):', choices:['BPH','Contrast exposure, aminoglycosides, prolonged ischemia, rhabdomyolysis','Pregnancy','Asthma'], answer:1, why:'Tubular injury from toxins/ischemia/rhabdo.'},
    {cat:'Renal', stem:'CKD staging eGFR pair that is correct:', choices:['G2: 15â€“29','G3b: 45â€“59','G4: 15â€“29','G1: 30â€“44'], answer:2, why:'G1 â‰¥90 with damage; G2 60â€“89; G3a 45â€“59; G3b 30â€“44; G4 15â€“29; G5 <15.'},
    {cat:'Renal', stem:'Initial management priorities in AKI include:', choices:['Immediate dialysis in all cases','Volume assessment with isotonic fluids if hypovolemic, stop nephrotoxins, adjust meds, treat cause','High-dose steroids','Empiric antibiotics always'], answer:1, why:'Supportive care + remove insults; dialysis for AEIOU indications.'},
    {cat:'Renal', stem:'CKD endocrine/cardiovascular complications include:', choices:['Hypokalemia and low PTH','Secondary hyperparathyroidism, anemia of EPO deficiency, accelerated atherosclerosis and LVH','Cushing syndrome','Hyperthyroidism'], answer:1, why:'CKD â†’ â†“EPO, â†‘PTH, vascular calcification/ASCVD, LVH from HTN/volume.'},
    {cat:'Renal', stem:'Renal calculi: most common stone type and preventive advice:', choices:['Cystine; reduce salt only','Uric acid; avoid calcium','Calcium oxalate; increase fluids, reduce sodium, normal calcium intake','Struvite; stop all dairy'], answer:2, why:'Ca oxalate predominates; high fluids, â†“Na, normal Ca reduce recurrence.'},
    {cat:'Renal', stem:'Albuminuria categorization relevant to CKD diagnosis:', choices:['A1 â‰¥300 mg/g','A2 30â€“300 mg/g','A3 <30 mg/g','Albuminuria not used'], answer:1, why:'A1 <30, A2 30â€“300, A3 >300 mg/g (ACR).'},
    {cat:'Renal', stem:'Which is a hallmark of uremic syndrome?', choices:['Polycythemia, tremor, jaundice','Pericarditis, encephalopathy, platelet dysfunction, nausea','Hypotension, weight gain, asthma','Hyperthyroidism, vision loss'], answer:1, why:'Uremia affects multiple systems: neuro, GI, cardiac, heme.'},
    {cat:'Renal', stem:'Consequence of decreased renal Vitamin D activation:', choices:['Hypercalcemia and low PTH','Hypocalcemia with secondary hyperparathyroidism and renal osteodystrophy','No bone changes','Increased intestinal calcium absorption'], answer:1, why:'Loss of 1-Î± hydroxylase activity reduces calcium absorption â†’ â†‘PTH.'},
    {cat:'Renal', stem:'CKD-associated dyslipidemia typically features:', choices:['Increased HDL only','Hypertriglyceridemia, â†‘apoB lipoproteins, impaired clearance of TG-rich particles','Very low LDL','No lipid abnormalities'], answer:1, why:'CKD â†’ â†‘TG, VLDL, remnants; HDL often dysfunctional.'},
    {cat:'Renal', stem:'Risk factors for urge incontinence (overactive bladder) include:', choices:['Young age and dehydration','Stroke, Parkinson disease, multiple sclerosis, aging, bladder irritants (caffeine, alcohol)','BPH only','Recent hysterectomy always'], answer:1, why:'Neurologic disease/aging and irritants increase detrusor overactivity.'},
    {cat:'Renal', stem:'Renal calcium oxalate stone pathogenesis most closely involves:', choices:['Urease-producing bacteria forming struvite','Supersaturation of urine with calcium and oxalate leading to crystal nucleation and growth in low urine volume','Cystinuria causing hexagonal crystals','Uric acid precipitation at high urine pH'], answer:1, why:'Low volume/high solute â†’ supersaturation and crystallization; most common stone type.'},
     {cat:'Renal', stem:'Chronic kidney disease (CKD) is diagnosed when kidney abnormalities persist for **how long**?', choices:[
    '>1 week','>1 month','â‰¥3 months','â‰¥12 months'
  ], answer:2, why:'KDIGO definition: structural or functional abnormality for â‰¥3 months with health implications.'},

  {cat:'Renal', stem:'Which **meets CKD criteria** even if eGFR â‰¥60 mL/min/1.73 mÂ²?', choices:[
    'Albumin-to-creatinine ratio (ACR) 10 mg/g for 2 weeks',
    'ACR â‰¥30 mg/g for â‰¥3 months',
    'Single eGFR 55 mL/min/1.73 mÂ²',
    'Microscopic hematuria once'
  ], answer:1, why:'Markers of kidney damage (e.g., persistent ACR â‰¥30 mg/g) for â‰¥3 months qualify as CKD regardless of eGFR.'},

  {cat:'Renal', stem:'**Uremic syndrome** commonly presents with which constellation?', choices:[
    'Polycythemia, tremor, jaundice',
    'Pericarditis, encephalopathy/asterixis, platelet dysfunction with bleeding, nausea',
    'Hypotension, asthma, pancreatitis',
    'Hyperthyroidism, vision loss'
  ], answer:1, why:'Multisystem involvement: neuro, CV (uremic pericarditis), hematologic (platelet dysfunction), GI, derm, endocrine/metabolic.'},

  {cat:'Renal', stem:'What best explains **CKD-associated dyslipidemia**?', choices:[
    'Increased HDL-mediated reverse transport',
    'Reduced lipoprotein lipase activity and insulin resistance â†’ â†‘TG-rich lipoproteins and small dense LDL',
    'Absent LDL entirely',
    'Markedly elevated HDL only'
  ], answer:1, why:'CKD impairs TG clearance (â†“LPL/HTGL), alters apolipoproteins, and increases TG-rich remnants; HDL often low/dysfunctional.'},

  {cat:'Renal', stem:'**ACE inhibitors** slow CKD progression primarily by:', choices:[
    'Constriction of afferent arteriole to lower GFR',
    'Efferent arteriolar dilation reducing intraglomerular pressure and proteinuria',
    'Increasing aldosterone',
    'Raising intraglomerular pressure to â€œnormalizeâ€ filtration'
  ], answer:1, why:'Efferent dilation lowers glomerular capillary pressure and albumin leak, slowing progressionâ€”especially in albuminuric CKD.'},

  {cat:'Renal', stem:'Which **endocrine** complication is characteristic of CKD?', choices:[
    'Primary hyperparathyroidism with hypercalcemia',
    'Secondary hyperparathyroidism due to low 1,25-(OH)â‚‚D and hypocalcemia',
    'Cushing syndrome',
    'Graves disease'
  ], answer:1, why:'CKD-MBD: reduced vitamin D activation â†’ hypocalcemia â†’ secondary HPT; bone disease (renal osteodystrophy).'},
  
  {cat:'Renal', stem:'Which **cardiovascular** complication is most linked to CKD morbidity/mortality?', choices:[
    'Tricuspid atresia',
    'Accelerated atherosclerosis, LV hypertrophy, vascular calcification, and heart failure',
    'Isolated pericardial cysts',
    'Atrial septal defect'
  ], answer:1, why:'HTN/LVH, arterial stiffness/calcification, ASCVD, and HF drive excess CV risk in CKD.'},

  {cat:'Renal', stem:'**Albuminuria categories** relevant to CKD staging:', choices:[
    'A1 â‰¥300 mg/g; A2 30â€“300 mg/g; A3 <30 mg/g',
    'A1 <30 mg/g; A2 30â€“300 mg/g; A3 >300 mg/g',
    'A1 30â€“300 mg/g; A2 >300 mg/g; A3 any',
    'Albuminuria is not used in CKD'
  ], answer:1, why:'A1 <30; A2 30â€“300; A3 >300 mg/g (ACR); combine with G stage for prognosis.'},

  {cat:'Renal', stem:'**Indications for urgent dialysis (AEIOU)** include all EXCEPT:', choices:[
    'Severe metabolic acidosis',
    'Life-threatening hyperkalemia',
    'Toxic alcohol ingestion',
    'Mild asymptomatic anemia'
  ], answer:3, why:'AEIOU: Acidosis, Electrolytes, Intoxications, Overload, Uremiaâ€”not mild anemia.'},
     {cat:'Renal', stem:'**Uncomplicated cystitis** typical presentation:', choices:['Fever, CVA tenderness','Dysuria, frequency, urgency without systemic toxicity','Urinary retention with overflow','Gross hematuria only'], answer:1, why:'Irritative voiding symptoms; usually afebrile.'},
  {cat:'Renal', stem:'**Complicated UTI** includes all EXCEPT:', choices:['Male sex','Pregnancy','Indwelling catheter/neurogenic bladder','Healthy nonpregnant woman with no abnormalities'], answer:3, why:'That scenario is uncomplicated.'},
  {cat:'Renal', stem:'**Acute pyelonephritis** hallmark finding:', choices:['Bland UA','WBC casts with fever and CVA tenderness','Only microscopic hematuria','Afebrile always'], answer:1, why:'Upper tract infection with systemic features.'},
  {cat:'Renal', stem:'**BPH** pathophysiology:', choices:['Autoimmune prostatitis','DHT-mediated stromal/epithelial hyperplasia (transition zone)','Congenital stricture','Prostate cancer'], answer:1, why:'Androgen-driven enlargement.'},
  {cat:'Renal', stem:'First-line for rapid LUTS relief in **BPH**:', choices:['5-ARI','Alpha-1 blocker','Loop diuretic','Antibiotic'], answer:1, why:'Smooth muscle relaxation quickly improves flow.'},
  {cat:'Renal', stem:'**CKD definition** time criterion:', choices:['>1 week','>1 month','â‰¥3 months','â‰¥6 months'], answer:2, why:'KDIGO â‰¥3 months.'},
  {cat:'Renal', stem:'**Albuminuria categories (ACR, mg/g):**', choices:['A1 â‰¥300; A2 30â€“300; A3 <30','A1 <30; A2 30â€“300; A3 >300','A1 30â€“300; A2 >300; A3 any','Albuminuria not used'], answer:1, why:'A1 <30; A2 30â€“300; A3 >300.'},
  {cat:'Renal', stem:'**eGFR staging** correct pair:', choices:['G4: 15â€“29','G3b: 45â€“59','G2: 15â€“29','G1: 30â€“44'], answer:0, why:'G4 = 15â€“29; G3a 45â€“59; G3b 30â€“44.'},
  {cat:'Renal', stem:'**ACE inhibitors** slow CKD progression by:', choices:['Afferent constriction','Efferent dilation â†’ â†“intraglomerular pressure and proteinuria','Raising aldosterone','Increasing glomerular pressure'], answer:1, why:'Lower glomerular pressure and albumin leak.'},
  {cat:'Renal', stem:'**Uremic syndrome** hematologic effect:', choices:['Polycythemia','Platelet dysfunction â†’ mucocutaneous bleeding','Leukemoid reaction','Eosinophilia'], answer:1, why:'Qualitative platelet defect from uremic toxins.'},
  {cat:'Renal', stem:'**CKD dyslipidemia** pattern best explained by:', choices:['High HDL function','â†“LPL/HTGL activity and insulin resistance â†’ â†‘TG-rich lipoproteins and small dense LDL','Absent LDL entirely','Marked HDL rise only'], answer:1, why:'Impaired clearance and altered apolipoproteins.'},
  {cat:'Renal', stem:'**Indications for urgent dialysis (AEIOU)** include all EXCEPT:', choices:['Refractory acidosis','Life-threatening hyperkalemia','Overload refractory to diuretics','Mild asymptomatic anemia'], answer:3, why:'Anemia alone â‰  urgent dialysis.'},
  {cat:'Renal', stem:'**Prerenal AKI** profile:', choices:['BUN:Cr <10, FeNa >2%','BUN:Cr >20, FeNa <1%, bland sediment','Eosinophiluria','Muddy brown casts'], answer:1, why:'Hypoperfusion with intact tubules.'},
  {cat:'Renal', stem:'**Intrinsic ATN** hallmark:', choices:['FeNa <1% with hyaline casts','FeNa >2% with muddy brown granular casts','No casts','Pure hematuria'], answer:1, why:'Tubular injury pattern.'},
  {cat:'Renal', stem:'**Renal calculi** most common type and prevention:', choices:['Cystine; no sodium restriction','Uric acid; stop calcium intake','Calcium oxalate; â†‘fluids, â†“sodium, normal calcium diet','Struvite; high-calcium diet'], answer:2, why:'High fluids + sodium restriction reduce recurrence.'},
  {cat:'Renal', stem:'**Urge incontinence** mechanism/risk set:', choices:['Outlet obstruction; BPH only','Detrusor overactivity; aging, stroke, Parkinson disease, bladder irritants','Functional barrier; mobility/cognition only','Fistula'], answer:1, why:'Overactive bladder with neurologic/irritant risks.'},
  {cat:'Renal', stem:'**AKI initial management** priorities:', choices:['Dialysis immediately in all','Volume assessment; isotonic fluids if hypovolemic; stop nephrotoxins; treat cause; dose-adjust meds','High-dose steroids for all','Empiric antibiotics always'], answer:1, why:'Supportive care + remove insults; dialysis for AEIOU.'},
  {cat:'Renal', stem:'**Vitamin D activation failure** in CKD causes:', choices:['Hypercalcemia with low PTH','Hypocalcemia â†’ secondary hyperparathyroidism and renal osteodystrophy','No bone changes','Increased intestinal calcium absorption'], answer:1, why:'1,25-(OH)â‚‚D low â†’ â†“Ca absorption â†’ â†‘PTH.'},
  {cat:'Renal', stem:'**Cardiovascular** complication cluster in CKD:', choices:['Hypotension only','HTN, LVH, vascular calcification, accelerated ASCVD, HF','Only pericardial cysts','ASD'], answer:1, why:'Major driver of mortality in CKD.'},
  {cat:'Renal', stem:'**BPH** risk factors include:', choices:['Age <30','Increasing age, androgens, family history, metabolic syndrome/obesity','Low testosterone always','Prior UTI only'], answer:1, why:'Prevalence rises with age; metabolic factors matter.'},
  ],
};

// ==== Build combined question set based on selected sections ====
const sections = Object.keys(BANK);
let selected = new Set(sections); // default: include all
let pool = []; // indices into a flattened array
let flat = []; // flattened question list
let order = []; let idx=0; let answers=[]; let correct=[]; let submitted=[];
let showExplain=false; let mode='exam';
let timerInt=null, seconds=0;

function flatten(){
  flat=[]; pool=[];
  sections.forEach(sec=>{
    if(!selected.has(sec)) return;
    BANK[sec].forEach(q=> flat.push({...q, section:sec}));
  });
  order = flat.map((_,i)=>i);
}

function shuffle(a){ for(let i=a.length-1;i>0;i--){ const j=Math.floor(Math.random()*(i+1)); [a[i],a[j]]=[a[j],a[i]]; } return a; }
const el=id=>document.getElementById(id);
function formatTime(s){ const m=Math.floor(s/60).toString().padStart(2,'0'); const r=(s%60).toString().padStart(2,'0'); return `${m}:${r}`; }

function buildTabs(){
  const box = document.getElementById('sectionTabs');
  box.innerHTML='';
  sections.forEach(sec=>{
    const b=document.createElement('button'); b.textContent=sec; b.className='pill';
    if(selected.has(sec)) b.classList.add('active');
    b.addEventListener('click',()=>{ if(selected.has(sec)) selected.delete(sec); else selected.add(sec); buildTabs(); });
    box.appendChild(b);
  });
}

function start(){
  // ensure at least one section selected
  if(selected.size===0){ alert('Select at least one section.'); return; }
  flatten(); shuffle(order); idx=0;
  answers = Array(order.length).fill(-1);
  correct = Array(order.length).fill(false);
  submitted = Array(order.length).fill(false);
  seconds=0; clearInterval(timerInt); timerInt=setInterval(()=>{seconds++; el('timer').textContent=formatTime(seconds);},1000);
  render(); updateProgress(); el('review').innerHTML='';
}

function render(){
  el('qTotal').textContent = order.length;
  if(order.length===0){ el('qStem').textContent='No questions: choose sections and press Start.'; el('choices').innerHTML=''; document.getElementById('explain').style.display='none'; return; }
  const k=order[idx]; const q=flat[k];
  el('qIndex').textContent = idx+1; el('qCat').textContent = q.section;
  el('qStem').textContent = q.stem;
  const chosen=answers[idx];
  const box=el('choices'); box.innerHTML='';
  q.choices.forEach((c,i)=>{
    const row=document.createElement('label'); row.className='choice';
    if(submitted[idx]){
      if(i===q.answer) row.classList.add('correct');
      if(chosen===i && chosen!==q.answer) row.classList.add('incorrect');
    }
    const input=document.createElement('input'); input.type='radio'; input.name='choice'; input.value=i; input.checked=(chosen===i);
    input.addEventListener('change',()=>{ answers[idx]=i; showExplain=false; document.getElementById('explain').style.display='none'; updateProgress(); });
    const span=document.createElement('span'); span.textContent=c; row.appendChild(input); row.appendChild(span); box.appendChild(row);
  });
  if(showExplain && submitted[idx]){ showRationale(); } else { document.getElementById('explain').style.display='none'; }
}

function submit(){
  if(order.length===0) return;
  const k=order[idx]; const q=flat[k]; const a=answers[idx];
  if(a<0){ alert('Select an answer.'); return; }
  const isRight = a===q.answer; correct[idx]=isRight; submitted[idx]=true; showExplain=true;
  // decorate
  const nodes = el('choices').querySelectorAll('.choice');
  nodes.forEach((n,i)=>{ n.classList.remove('correct','incorrect'); if(i===q.answer) n.classList.add('correct'); if(i===a && a!==q.answer) n.classList.add('incorrect'); });
  updateProgress(); showRationale(); buildReviewSheet();
}

function next(){ if(order.length===0) return; if(idx<order.length-1){ idx++; render(); } else { alert('End of set. Press Start to reshuffle or change sections.'); } }
function prev(){
  if(order.length===0) return;
  if(idx > 0){
    idx--;
    render();
  } else {
    alert('This is the first question.');
  }
}

function shuffleAll(){
  if(selected.size === 0){ alert('Select at least one section.'); return; }
  // If we haven't started yet, just start (builds pool + shuffles)
  if(!order || order.length === 0){ start(); return; }
  // Reshuffle the current pool and reset progress/timer
  shuffle(order);
  idx = 0;
  answers  = Array(order.length).fill(-1);
  correct  = Array(order.length).fill(false);
  submitted= Array(order.length).fill(false);
  showExplain = false;
  document.getElementById('explain').style.display = 'none';
  el('review').innerHTML = '';
  seconds = 0;
  clearInterval(timerInt);
  timerInt = setInterval(()=>{ seconds++; el('timer').textContent = formatTime(seconds); }, 1000);
  render();
  updateProgress();
}

function updateProgress(){
  const done = answers.filter(x=>x>=0).length; const got = correct.filter(Boolean).length; const total = order.length||1;
  el('answered').textContent = done; const pct = Math.round((got/(done||1))*100); el('score').textContent = `${got} / ${done} (${pct}%)`;
  el('bar').style.width = `${Math.round((done/total)*100)}%`;
}

function showRationale(){
  const k=order[idx]; const q=flat[k]; const box=document.getElementById('explain');
  box.style.display='block';
  const wasRight = correct[idx];
  box.innerHTML = `<strong>${wasRight?'<span class=good>Correct</span>':'<span class=bad>Incorrect</span>'}</strong> â€” ${q.why}`;
}

function buildReviewSheet(){
  let html='';
  order.forEach((k,ii)=>{
    const q=flat[k]; const chosen=answers[ii];
    if(mode==='review' && correct[ii]) return; // hide correct in review mode
    if(chosen<0 && mode==='review') return;
    const status = correct[ii] ? '<span class="good">âœ”</span>' : '<span class="bad">âœ–</span>';
    html += `<div style="margin-bottom:10px"><div>${status} <strong>Q${ii+1} (${q.section})</strong>: ${q.stem}</div>`+
            `<div class="muted">Your answer: ${chosen>=0?q.choices[chosen]:'â€”'} | Correct: <strong>${q.choices[q.answer]}</strong></div>`+
            `<div>${q.why}</div></div>`;
  });
  el('review').innerHTML = html || '<em>No items to review yet.</em>';
}

document.getElementById('startBtn').addEventListener('click', start);
document.getElementById('submitBtn').addEventListener('click', submit);
document.getElementById('nextBtn').addEventListener('click', next);
document.getElementById('mode').addEventListener('change',(e)=>{ mode=e.target.value; if(mode==='review'){ buildReviewSheet(); } render(); });
document.getElementById('startBtn').addEventListener('click', start);
document.getElementById('shuffleBtn').addEventListener('click', shuffleAll);
document.getElementById('prevBtn').addEventListener('click', prev);
document.getElementById('submitBtn').addEventListener('click', submit);
document.getElementById('nextBtn').addEventListener('click', next);
document.getElementById('mode').addEventListener('change',(e)=>{
  mode = e.target.value;
  if(mode==='review'){ buildReviewSheet(); }
  render();
});

buildTabs();
// Preload with everything selected but wait for Start
flatten(); el('qTotal').textContent = order.length; // shows 0 until Start
</script>
</body>
</html>
